<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d2 20140930//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName ACSJournal-v102.dtd?><?SourceDTD.Version 1.02?><?ConverterInfo.XSLTName acs2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Proteome Res</journal-id><journal-id journal-id-type="iso-abbrev">J. Proteome Res</journal-id><journal-id journal-id-type="publisher-id">pr</journal-id><journal-id journal-id-type="coden">jprobs</journal-id><journal-title-group><journal-title>Journal of Proteome Research</journal-title></journal-title-group><issn pub-type="ppub">1535-3893</issn><issn pub-type="epub">1535-3907</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4642221</article-id><article-id pub-id-type="doi">10.1021/acs.jproteome.5b00681</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title>Peptidomics of Circular Cysteine-Rich Plant Peptides:Analysis of the Diversity of Cyclotides from <italic>Viola tricolor</italic> by Transcriptome and Proteome Mining</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Hellinger</surname><given-names>Roland</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Koehbach</surname><given-names>Johannes</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Soltis</surname><given-names>Douglas E.</given-names></name><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>Carpenter</surname><given-names>Eric J.</given-names></name><xref rid="aff4" ref-type="aff">&#x022a5;</xref></contrib><contrib contrib-type="author" id="ath5"><name><surname>Wong</surname><given-names>Gane Ka-Shu</given-names></name><xref rid="aff4" ref-type="aff">&#x022a5;</xref><xref rid="aff5" ref-type="aff">&#x02225;</xref><xref rid="aff6" ref-type="aff">&#x02207;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath6"><name><surname>Gruber</surname><given-names>Christian W.</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><aff id="aff1"><label>&#x02020;</label>Center
for Physiology and Pharmacology, <institution>Medical
University of Vienna</institution>, Schwarzspanierstrasse 17, 1090 Vienna, <country>Austria</country></aff><aff id="aff2"><label>&#x02021;</label>School
of Biomedical Sciences, <institution>The University of
Queensland</institution>, St. Lucia, Queensland 4072, <country>Australia</country></aff><aff id="aff3"><label>&#x000a7;</label>Florida
Museum of Natural History, <institution>University of
Florida</institution>, Gainesville, Florida 32611, <country>United
States</country></aff><aff id="aff4"><label>&#x022a5;</label>Department
of Biological Sciences, <institution>University of Alberta</institution>, Edmonton, Alberta T6G 2E9, <country>Canada</country></aff><aff id="aff5"><label>&#x02225;</label>Department
of Medicine, <institution>University of Alberta</institution>, Edmonton, Alberta T6G 2E1, <country>Canada</country></aff><aff id="aff6"><label>&#x02207;</label>BGI-Shenzhen,
Beishan Industrial Zone, Yantian District, Shenzhen 518083, <country>China</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Tel: <phone>+43-1-40160-31390</phone>. Fax: <fax>+43-1-40160-931300</fax>. E-mail: <email>christian.w.gruber@meduniwien.ac.at</email>.</corresp></author-notes><pub-date pub-type="epub"><day>24</day><month>09</month><year>2015</year></pub-date><pub-date pub-type="ppub"><day>06</day><month>11</month><year>2015</year></pub-date><volume>14</volume><issue>11</issue><fpage>4851</fpage><lpage>4862</lpage><history><date date-type="received"><day>21</day><month>07</month><year>2015</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2015 American Chemical Society</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>American Chemical Society</copyright-holder><license><license-p>This is an open access article published under a Creative Commons Attribution (CC-BY) <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html">License</ext-link>, which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr-2015-006814_0006" id="ab-tgr1"/></p><p>Cyclotides are plant-derived mini proteins. They are genetically
encoded as precursor proteins that become post-translationally modified
to yield circular cystine-knotted molecules. Because of this structural
topology cyclotides resist enzymatic degradation in biological fluids,
and hence they are considered as promising lead molecules for pharmaceutical
applications. Despite ongoing efforts to discover novel cyclotides
and analyze their biodiversity, it is not clear how many individual
peptides a single plant specimen can express. Therefore, we investigated
the transcriptome and cyclotide peptidome of <italic>Viola tricolor</italic>. Transcriptome mining enabled the characterization of cyclotide
precursor architecture and processing sites important for biosynthesis
of mature peptides. The cyclotide peptidome was explored by mass spectrometry
and bottom-up proteomics using the extracted peptide sequences as
queries for database searching. In total 164 cyclotides were discovered
by nucleic acid and peptide analysis in <italic>V. tricolor</italic>. Therefore, violaceous plants at a global scale may be the source
to as many as 150&#x0202f;000 individual cyclotides. Encompassing the
diversity of <italic>V. tricolor</italic> as a combinatorial library
of bioactive peptides, this commercially available medicinal herb
may be a suitable starting point for future bioactivity-guided screening
studies.</p></abstract><kwd-group><kwd>circular peptides</kwd><kwd>cystine-knot</kwd><kwd>transcriptome</kwd><kwd>peptidomics</kwd><kwd>Violaceae</kwd><kwd>ribosomally synthesized
and post-translationally modified peptides</kwd><kwd>natural products</kwd><kwd>mass spectrometry</kwd><kwd>1kp</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>pr5b00681</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>pr-2015-006814</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><title>Introduction</title><p>Cyclotides are gene-encoded cysteine-rich plant peptides. These
peptides appear to be part of the plant defense system, based on observations
that certain cyclotides exhibit insecticidal<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> or antimicrobial activities.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> Their characteristic
structure comprises a head-to-tail cyclized cystine-knot motif, which
confers them great stability and resistance to enzymatic, thermal,
and chemical degradation.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> Hence, cyclotides
offer an interesting scaffold for peptide drug development,<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> and they have been utilized as templates for
grafting of bioactive epitopes onto the stabilized framework.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> Furthermore, cyclotides display a variety of
intrinsic activities. For example, they are ligands of the human oxytocin
and vasopressin V<sub>1a</sub> receptors, both members of the G protein-coupled
receptor family,<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> and they inhibit the
activity of human prolyl oligopeptidase, a serine-protease involved
in the processing of neuropeptides.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> These
properties were discovered in bioassay-guided fractionation approaches
using plant-derived peptide extracts as starting materials; needless
to say, a robust and efficient analytical workflow is crucial to determine
the molecular structure of each bioactive cyclotide. Therefore, advances
in the discovery and identification of cyclotides are of great interest
to provide novel peptide candidates for drug discovery<sup><xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref9">9</xref></sup> and pharmacological applications.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup></p><p>Cyclotide distribution within flowering plants has been explored
extensively, and today members of the angiosperm families Cucurbitaceae,
Fabaceae, Solanaceae, Poaceae, Rubiaceae, and Violaceae are known
to express these circular peptides.<sup><xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref12">12</xref></sup> All species
of Violaceae examined hitherto are well-known as a rich source of
cyclotides. The violets are the only plant family that ubiquitously
contain cyclotides in every species sampled to date.<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> Within the Violaceae m&#x000e9;nage the species <italic>Viola tricolor</italic> L. is well-known as a traditional medicinal
plant.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> In particular, herbal extracts
of <italic>V. tricolor</italic> have been described to treat inflammatory
diseases such as inflammatory atopic dermatitis or psoriasis.<sup><xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref15">15</xref></sup> Although plants contain a number of different bioactive substances,<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> a recent study highlighted that a cyclotide-enriched <italic>V. tricolor</italic> extract inhibited the proliferation of activated
peripheral blood mononuclear cells.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> Earlier
it was demonstrated that cyclotides isolated from <italic>V. tricolor</italic> are antiproliferative agents against cancer cell lines.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> Cyclotides have also been discovered in other
members of Violaceae, including <italic>V. odorata</italic> L., <italic>V. yedoensis</italic> Mak., <italic>Melicitus ramiflorus</italic> J.R. &#x00026; G. Forster, and <italic>Hybanthus floribundus</italic> Lindl. F.Muell., just to name a few.<sup><xref ref-type="bibr" rid="ref18">18</xref>&#x02212;<xref ref-type="bibr" rid="ref27">27</xref></sup> In addition, cyclotides isolated from species of Violaceae have
been intensively investigated by mass spectrometry (MS) and nuclear
magnetic resonance (NMR) spectroscopy to provide structural data and
insight into their stability and chemical folding.<sup><xref ref-type="bibr" rid="ref28">28</xref>&#x02212;<xref ref-type="bibr" rid="ref35">35</xref></sup> As a consequence of the cyclic nature of cyclotides and therefore,
the lack of C- and N-termini, enzymatic processing is required to
open the backbone ring. Given that an enzymatic digest of a peptide/protein-enriched
plant extract yields thousands of peptides, the analysis of cyclotides
in nonpurified preparations is extremely challenging, in particular
due to the lack of appropriate nucleic acid/protein data sets available
for proteomics analysis. To date, only laborious peptide purification
combined with manual <italic>de novo</italic> sequencing appears to
be suitable for precise sequence elucidation.<sup><xref ref-type="bibr" rid="ref21">21</xref>,<xref ref-type="bibr" rid="ref36">36</xref></sup> More recently, next generation sequencing and bioinformatics have
emerged as potential approaches for cyclotide discovery.<sup><xref ref-type="bibr" rid="ref36">36</xref>&#x02212;<xref ref-type="bibr" rid="ref39">39</xref></sup></p><p>In this study we combined transcriptome mining and MS to identify
and characterize novel vitri cyclotides from <italic>V. tricolor</italic>. Transcriptome analysis provided new insights about the structure
of cyclotide precursors, processing sites, and mature peptide sequences.
Furthermore, we characterized the cyclotide peptidome by MALDI&#x02212;TOF/TOF
and LC&#x02013;MS/MS. Systematic analysis and comparison of cyclotide
identification at the nucleic acid level with application of different
proteomics techniques provided the first comprehensive picture about
cyclotide diversity and their post-translational modifications (PTM)
in a single plant species. The outcome of this work may serve as a
starting point for a routine high-throughput proteomics identification
of cyclotides and other ribosomally synthesized and post-translationally
modified natural peptide products.</p></sec><sec id="sec2"><title>Experimental Section</title><sec id="sec2.1"><title>Chemicals</title><p>Acetonitrile (AcN), methanol (MeOH), dichlormethane,
trifluoroacetic acid (TFA), and H<sub>2</sub>O were purchased as HPLC
or LC-MS grade from Carl Roth (Karlsruhe, Germany). Dithiothreitol
(DTT), &#x003b1;-cyano-hydroxy cinnamic acid, trypsin (sequencing grade),
and iodoacetamide (IAA) were purchased as Bioultra grade from Sigma-Aldrich
(Sigma-Aldrich, Vienna, Austria). Endoproteinase Glu C (sequencing
grade) was purchased from New England Biolabs (Ipswich, MA).</p></sec><sec id="sec2.2"><title>Plant Material, RNA Extraction and Sequencing</title><p><italic>V. tricolor</italic> was cultivated in a planting area near the entrance
of Brywood, 16th avenue and NW 27th Terrace, Gainesville, Florida
32605 (coordinates 29&#x000b0;40&#x02032;00.6&#x02033;N 82&#x000b0;21&#x02032;48.2&#x02033;W).
Fresh leaves of <italic>V. tricolor</italic> were identified by D.S.
and colleagues and collected directly into liquid nitrogen. A voucher
specimen (Soltis and Miles 2930) was deposited at the University of
Florida Herbarium (FLAS). RNA was isolated using a Trizol/RNAqueous-Midi
Kit (Ambion, Paisley, UK). Samples were sequenced as an indexed RNaseq
library on an Illumina GA II machine (Illumina, San Diego, CA).<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> Sequencing was paired-end (73 bp +75 bp) and
produced a total of over 2.3 Gbp. The sequences were assembled into
scaffolds using SOAPdenovo-Trans (Beijing Genomics Institute, China).<sup><xref ref-type="bibr" rid="ref41">41</xref></sup></p></sec><sec id="sec2.3"><title>Transcriptome Analysis of Cyclotide Precursor Proteins</title><p>Transcriptome data of <italic>V. tricolor</italic> were accessed
via the 1kp-project (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.onekp.com">www.onekp.com</uri>). BLAST searches were
conducted against these scaffolds. The <italic>V. tricolor</italic> data were accessed via tBLASTn using a set of published cyclotide
precursor sequences as queries (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.cybase.org.au">www.cybase.org.au</uri>). Resulting
hits and contig sequences were translated and annotated based on homology
to known cyclotide precursors according to a similar methodology as
described recently.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> Briefly, hits were
collected and translated into their respective amino acid sequence
(six-frame translation). Open reading frames were identified via manual
sequence assignments. All transcriptome contig sequence IDs, nucleotide
sequence data of precursors vitri 1 to vitri 99, as well as protein
translations are listed in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5b00681/suppl_file/pr5b00681_si_001.pdf">Supplementary Data S-1</ext-link>. Sequence alignments were prepared using ClustalW (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ebi.ac.uk/Tools/msa/clustalw2/">www.ebi.ac.uk/Tools/msa/clustalw2/</uri>). Novel full-length precursor
sequences are available in the GenBank database under the accession
numbers KT203800&#x02013;KT203810. Any ambiguous or erroneous assembly was analyzed by Transrate to
identify mis-assembled contigs or assembly artifacts (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.stevekellylab.com/software/transrate">http://www.stevekellylab.com/software/transrate</uri>).</p></sec><sec id="sec2.4"><title>Peptide Extraction</title><p>Dried <italic>V. tricolor</italic> total herbaceous plant material (Herba Violae Tricoloris plv.) was
obtained from Dr. Kottas Pharma GmbH (Vienna, Austria). The peptide
extraction was performed according to well-established protocols.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> Briefly, plant material was extracted in a dichloromethane/MeOH
1:1 (v/v) solution for 24 h. Afterward the addition of one-half volume
of ddH<sub>2</sub>O allowed liquid&#x02013;liquid phase extraction.
The MeOH/water phase encompasses all moderately hydrophobic plant
constituents such as peptides, whereas lipophilic plant pigments are
enriched in the dichloromethane phase. The MeOH/water phase was further
treated in batch by solid phase extraction. Zeoprep 60 &#x000c5;, C<sub>18</sub> irregular 40&#x02013;63 &#x003bc;m material (Zeochem, Uetikon,
Switzerland) was used according to the manufacturer&#x02019;s recommendation
with surface activation by MeOH, equilibration with 0.1% TFA and peptide
elution with AcN/ddH<sub>2</sub>O/TFA 80/20/0.1% (v/v/v). The eluted
extract was freeze-dried and will be referred to as &#x0201c;vitri
extract&#x0201d;.</p></sec><sec id="sec2.5"><title>HPLC Fractionation</title><p>Fractionation of vitri extract was
performed using a Dionex Ultimate 3000 HPLC system (Thermo Fisher
Scientific, Waltham, MA) equipped with a binary pump, autosampler,
multiwavelength detector, and a fraction collector. Chromeleon application
software v. 6.80 was used to control the HPLC. Chromatography was
performed using a preparative Dichrom Kromasil column (dichrom GmbH,
Marl, Germany; 250 &#x000d7; 20 mm, spherical C<sub>18</sub> modified
particles, 10 &#x003bc;m, 110 &#x000c5;). Mobile phase eluent A consisted
of 0.1% TFA (aqueous) and mobile phase eluent B consisted of AcN/ddH<sub>2</sub>O/TFA 90/10/0.08% (v/v/v). The flow rate was set to 8 mL/min.
Peptide separation on column was achieved with linear stepwise gradients
(0&#x02032;-5% B, 5&#x02032;-5% B, 12.5&#x02032;-20% B, 62.5&#x02032;-70%
B, 63.5&#x02032;-99% B, 65&#x02032;-99% B, 66&#x02032;-5% B and 72&#x02032;-5%
B). Fractions of 40 mL (5 min) each, starting at 20% eluent B, were
collected and lyophilized. The dried samples were kept at &#x02212;20
&#x000b0;C until further analysis, e.g., mass deconvolution of cyclotide
mass signals or automated MS/MS sequencing and database search of
cyclotides for peptide identification in the proteomics workflow.</p></sec><sec id="sec2.6"><title>Sample Preparation for Mass Spectrometry</title><p>For MS-based
analysis via MALDI&#x02212;TOF or LC&#x02212;MS vitri extract was dissolved
in 0.1% TFA (aqueous) at a concentration of 3 mg/mL. For proteolytic
digest the extract was dissolved in 0.1 M NH<sub>4</sub>HCO<sub>3</sub> (pH 7.8) at a concentration of 3 mg/mL. Any insoluble material was
removed by centrifugation at 12000<italic>g</italic> for 10 min, and
the supernatant was used for further analysis. For proteomics analysis
by MS/MS an aliquot of peptide solution (20&#x02013;40 &#x003bc;L) was
used for reduction, alkylation, and proteolytic digest. Briefly, disulfides
were reduced with 20 mM dithiothreitol (DTT) for 1 h at 37 &#x000b0;C.
Free thiols were carbamidomethylated using 100 mM iodoacetamide for
20 min at 23 &#x000b0;C in the darkness. This reaction was quenched with
1 &#x003bc;L of 100 mM DTT for 10 min at 37 &#x000b0;C. The reduced and
alkylated samples were digested with trypsin (0.3 &#x003bc;g) or endoproteinase
GluC (0.6 &#x003bc;g) for 12&#x02013;16 h at 37 &#x000b0;C. Double digests
were performed accordingly, starting with trypsin digestion overnight,
followed by transient trypsin deactivation with DTT and addition of
endoproteinase GluC. For all samples, proteolytic digests were stopped
by adding TFA to a final concentration of 0.5% (v/v). The samples
were stored at &#x02212;20 &#x000b0;C until used for MS analysis.</p></sec><sec id="sec2.7"><title>Cyclotide Analysis by Mass Spectrometry</title><p>Vitri extracts
and fractions were analyzed via MALDI-TOF to evaluate the samples
for peaks in the cyclotide specific mass range of 2500&#x02013;4000
Da. MALDI-TOF analysis was performed on a 4800 reflector TOF/TOF (time-of-flight)
analyzer from ABSciex (Framingham, MA). Samples were mixed with a
saturated matrix solution of &#x003b1;-cyano-hydroxy cinnamic acid dissolved
in AcN/ddH<sub>2</sub>O/TFA 50/50/0.1% (v/v/v) at a ratio of 1:6,
and 0.5 &#x003bc;L of this mixture was transferred onto the target plate
to allow air-drying in the darkness. Mass accuracy was ensured by
daily calibration using Peptide Mix 1 [(bradykinin fragment 8&#x02013;39
(572.7 Da), angiotensin II (1046.2 Da), neurotensin (1672.9 Da), adrenocorticotropin
fragment 18&#x02013;39 (2465.7 Da) and bovine insulin chain B (3495.9
Da)] (Laserbiolabs, Sophia-Antipolis, France). MS spectra were recorded
using the reflector in positive ionization mode in a spectral range
between 2500 and 4500 Da. 2500&#x02013;3000 shots per spot were recorded
and accumulated. Laser intensity and amplifier adjustment were optimized
for maximal signal intensity. Vitri extracts were evaluated via LC&#x02013;MS
scan and mass signal deconvolution of MS<sup>1</sup> scans. MS scans
were processed with deconvolution to evaluate mass signals in the
cyclotide typical mass range of 2500&#x02013;4000 Da. Peptide extract
was analyzed via LC&#x02013;MS on a QqTOF compact (Bruker Daltonics,
Billerica, MA). Sample desalting and preconcentration were performed
with a trap column, and peptides were separated with a PepMap Acclaim
capillary column (Thermo Fisher Scientific; 150 &#x000d7; 0.3 mm, 2 &#x003bc;m
100 &#x000c5;) using a Dionex Ultimate 3000 UPLC system. The mobile phase
for the loading pump consisted of 0.1% TFA (aqueous); 0.1% formic
acid (aqueous) and AcN/ddH<sub>2</sub>O/formic acid 80/20/0.08% (v/v/v)
were used as mobile phases for chromatographic separation. The flow
rates were set to 25 &#x003bc;L/min for the loading pump and 6 &#x003bc;L/min
for the separation pump. The gradient for peptide separation was as
follows: 0&#x02032;-4% B, 10&#x02032;-4% B, 120&#x02032;-45% B, 125&#x02032;-99%
B, 132&#x02032;-99% B, 135&#x02032;-4% B and 150&#x02032;-4% B. The LC
QqTOF compact system was equipped with a captive nanoflow ionization
source, and sample ionization was achieved in the positive electron
ionization mode. Ion transfer parameters were kept constant for the
duration of one run: prepulse storage 5 &#x003bc;s, collision energy
transfer 9 eV, quadrupole energy 4 eV, funnel 1 400 Vpp, funnel 2
600 Vpp transfer time, and hexapole RF 400 Vpp. For collision energy
RF and for ion transfer time stepping from 200 to 1500 Vpp and 30&#x02013;150
&#x003bc;s were applied, respectively. External mass calibration was
achieved via direct infusion of the low concentration tuning mix from
Agilent Technologies (Santa Clara, CA). Furthermore, internal calibration
via lock mass was applied for each analytical run using calibrant
hexakis (1H, 1H, 4H-hexafluorobutyloxy)phosphazine (Agilent
Technologies). Base peak chromatograms in a signal window of 800&#x02013;2200
Da were processed with the &#x0201c;Compound Find&#x0201d; tool of the
Data Analysis software 4.21 (Build 393) (Bruker Daltonics). The &#x0201c;Deconvolution&#x0201d;
tool was applied to each identified compound using the following settings:
deconvolution of masses between 2500&#x02013;4000 Da, abundance cutoff
5%, maximum charge 4<sup>+</sup>, only consider [M + H]<sup>+</sup> ions of proteins or peptides. Each deconvolution list was manually
validated to exclude false-positive hits. Evidence by charge and/or
isotope pattern was recorded for each signal. For MS/MS experiments
of vitri extracts or vitri fractions F1&#x02013;F9 the chromatographic
conditions were identical as described for the mass signal deconvolution.
Peptide sequencing and automated identification by subsequent database
search were performed by MS/MS experiments on the QqTOF mass spectrometer
using a bottom-up shotgun proteomics approach. The mass spectrometer
was tuned and preoptimized to achieve best sequence coverage for precursors
up to 2200 Da, as commonly observed from proteolysis of cyclotides.
MS/MS sequencing was performed with a cycle time of 3 s and exclusion
criteria to reduce triggering of background signals. Scan range for
precursor recording was set to 50&#x02013;2200 Da with a minimal precursor
mass of 200 <italic>m</italic>/<italic>z</italic>. Peptides carrying
charges from 2<sup>+</sup> to 5<sup>+</sup> were set to trigger MS/MS.
High energy collision induced dissociation was performed under the
regime of a set energy set. This set applies optimized collision energy
for precursor signals based on the parameters: isolation <italic>m</italic>/<italic>z</italic>, isolation mass range width, and charge state
of the ion. The set followed the manufacturer&#x02019;s recommendations,
and it was not further modified by the experimenter.</p></sec><sec id="sec2.8"><title>Database Construction and Database Search</title><p>The &#x0201c;Proteinscape&#x0201d;
software package v. 3.1.5 474 (Build 20140711-1459) from Bruker Daltonics
together with the Mascot algorithm (Matrixscience, MA) was used for
data analysis and database search. The available cyclotide sequence
database ERA<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> was updated and customized
with the most recent data set of circular peptide sequences (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.cybase.org.au">www.cybase.org.au</uri>) and from recent cyclotide discovery studies<sup><xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref38">38</xref></sup> to yield in total 376 individual peptide sequences, including 55
novel precursors from the vitri transcriptome analysis of this study.
Additionally, contaminants were implemented into the custom database,
e.g., proteolytic fragments of keratins, bovine serum albumins and
proteases. The publicly available contaminant database (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://maxquant.org/contaminants.zip">http://maxquant.org/contaminants.zip</uri>) was provided by the Max Planck Institute of Biochemistry (Martinsried,
Germany). The custom cyclotide FASTA database can be provided upon
request. Peptide search parameters were set to peptide mass tolerance
&#x000b1;10 ppm, MS/MS tolerance &#x000b1;0.05 Da, number of possible <sup>13</sup>C atoms one, charge states 2<sup>+</sup> &#x02013; 5<sup>+</sup> and considered up to one missed cleavage in the peptide search.
Fixed modification was carbamidomethylation of cysteine side chains,
and variable modifications included methionine oxidation, tryptophan
modification to kynurenine and 3-hydroxykurenine, deamidation of asparagine
and glutamine and ethylation as well as methylation of glutamate or
aspartate residues, respectively. All peptides with more than one
possible precursor were assigned to the rank one candidate. Identified
proteins with a probability score &#x0003e;50 of two independent analyses
of at least one digest (as described in the section <xref rid="sec2.6" ref-type="other">Sample Preparation for Mass Spectrometry</xref>) were considered
to be valid; this threshold score has been found by manual MS/MS validation
to yield acceptable peptide assignment. Nevertheless, ion score cutoff
was set to &#x0003e;15 to consider and exclude low quality peptides from multiple
MS/MS triggering events. Cyclotides with a partial sequence and those
giving rise to more than one candidate peptide were evaluated manually
for assignment of one hit, and they were cross validated with the
vitri extract for native peptide mass signals of the reported MS/MS
precursor peak. The MS proteomics data have been deposited at the
ProteomeXchange Consortium (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://proteomecentral.proteomexchange.org">http://proteomecentral.proteomexchange.org</uri>) via the PRIDE partner repository with the data set identifier PXD002867
(project DOI: 10.6019/PXD002867).<sup><xref ref-type="bibr" rid="ref43">43</xref></sup></p></sec></sec><sec id="sec3"><title>Results and Discussion</title><p>Since the discovery of &#x0201c;<italic>kalata&#x0201d;</italic> plant
peptides in <italic>Oldenlandia affinis</italic> (R&#x00026;S) DC. by
Lorentz Gran<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> in the 1970s and the appreciation
of cyclotides as active substances in medical preparations for uterotonic
purpose,<sup><xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref44">44</xref>,<xref ref-type="bibr" rid="ref45">45</xref></sup> these ultrastable
peptides have been the focus of numerous investigations to delineate
their biological diversity, structural arrangement, and phylogenetic
distribution within the plant kingdom.<sup><xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref46">46</xref></sup> With an estimated 50&#x0202f;000
cyclotides present in Rubiaceae alone, the current rate and performance
of standard techniques of cyclotide discovery are clearly behind expectations,
and it needs further optimization.<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> So
far laborious purification of peptides has been necessary to obtain
accurate sequence information.<sup><xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref37">37</xref>,<xref ref-type="bibr" rid="ref39">39</xref></sup> Hence, not surprisingly, the number of novel cyclotides reported
by peptide sequencing in single studies to date is 18<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> and 24,<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> respectively, and
the overall number of cyclotides deposited in CyBase from &#x0003e;20 years
of research is currently at 922.<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> In the
era of high-throughput nucleic acid sequencing, new tools have become
available to examine cyclotide diversity on a genome/transcriptome
level.<sup><xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref37">37</xref>,<xref ref-type="bibr" rid="ref39">39</xref>,<xref ref-type="bibr" rid="ref47">47</xref></sup> Therefore, we aimed to discover as many cyclotides
as possible expressed in a single plant species and to examine their
molecular diversity by a combination of sequence analysis at the nucleic
acid level and MS studies at the peptide level. In addition, we performed
a state-of-the-art bottom-up proteomics approach using plant extracts
as well as HPLC fractionated samples to identify the sequences and
PTMs of many novel cyclotides present in <italic>V. tricolor</italic> and to establish a robust workflow for cyclotide analysis.</p><sec id="sec3.1"><title>Analysis of Cyclotide Expression at Nucleic Acid Level</title><p>To date, only two precursor sequences have been reported for <italic>V. tricolor</italic>,<sup><xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref49">49</xref></sup> and these were identified by
PCR-based cDNA sequencing. Peptide extraction and MS analysis yielded
another 14 mature cyclotides.<sup><xref ref-type="bibr" rid="ref17">17</xref>,<xref ref-type="bibr" rid="ref50">50</xref></sup> Little is known about
the variety of precursor sequences and how many cyclotides one plant
is capable of expressing. Therefore, it is of interest to gain insight
into the diversity of cyclotide precursors. <italic>V. tricolor</italic> transcriptome data were available via the 1kp-project (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.onekp.com">www.onekp.com</uri>) and identified by tBLASTn searches using known cyclotide precursor
sequences as queries (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.cybase.org.au">www.cybase.org.au</uri>). Contigs from
resulting homologous sequences have been translated and annotated
based on published cyclotide precursors. This approach led to the
identification of 98 unique precursor proteins encoding 108 peptide
sequences (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5b00681/suppl_file/pr5b00681_si_001.pdf">Supplementary Table S-1 and Supplementary Data S-1</ext-link>). These findings nearly double the number of precursors
compared to a very recent report suggesting that a single <italic>Viola</italic> species contains 53 cyclotide precursor sequences.<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> Most cyclotide precursors that have been discovered
only contain one cyclotide domain, but it is well-known that precursor
molecules may contain multiple cyclotide domains. In fact we identified
eight precursor proteins with two cyclotide domains (vitri precursor
18, 22, 27, 42, 72, 85, 91, and 94) and one precursor, vitri precursor
9, encoding for three cyclotide domains (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>A). Four cyclotide sequences (vitri 24/28,
36/37, 43/44 and 9<italic>a</italic>/53) have been found to be encoded
by two different precursor proteins. Analysis of precursor architecture
as well as putative processing sites provides further insight into
cyclotide biosynthesis in <italic>V. tricolor</italic> (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>B, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5b00681/suppl_file/pr5b00681_si_001.pdf">Supplementary Data S-2</ext-link>) and may also help to distinguish cyclotides from
other cysteine-rich plant peptides.<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> The
majority of identified precursor proteins, namely, 54 precursors contain
an asparagine (or aspartic acid) at the C-terminus of the cyclotide
domain followed by a highly conserved SL, or rarely SI, GL or AI in
the positions P&#x02032;1/P&#x02032;2. Surprisingly, 10 precursors differ
significantly in these common processing sites; vitri precursors 15,
16, 17, 19, 27a, 35, 40, 66, 76, and 79 lack the common asparagine
(aspartic acid) in their cyclotide domain vital for cyclization (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5b00681/suppl_file/pr5b00681_si_001.pdf">Supplementary Data S-1</ext-link>), and another seven peptides
completely lack a C-terminal tail sequence altogether (vitri precursors
8, 25, 32, 33, 46, 51 and 52). Hence this raises the question of whether
these peptides are being cyclized via different mechanisms or whether
they represent acyclic homologues (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5b00681/suppl_file/pr5b00681_si_001.pdf">Supplementary Table S-1, Supplementary Data S-1</ext-link>). The occurrence of linear
cyclotides has infrequently been reported for species of the Rubiaceae,
Violaceae, and Poaceae plant families.<sup><xref ref-type="bibr" rid="ref33">33</xref>,<xref ref-type="bibr" rid="ref51">51</xref>,<xref ref-type="bibr" rid="ref52">52</xref></sup> In fact, it was possible to confirm occurrence of
acyclic cyclotide homologues in <italic>V. tricolor</italic> (see
section <xref rid="sec3.3" ref-type="other">MS/MS Peptide Sequencing of Cyclotides</xref>). These acyclic peptides not only lack the N-terminal glycine and/or
the C-terminal asparagine, but the precursor proteins may also be
significantly shortened.<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> Besides containing
unusual processing motifs, vitri precursors 24 and 28 exhibit a long
C-tail region, which has not been observed previously in a cyclotide
precursor. The biosynthesis of cyclotides is still not fully understood;
however research has addressed the role of processing enzymes and
the involvement of single residues at the processing sites within
the peptide precursors (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5b00681/suppl_file/pr5b00681_si_001.pdf">Supplementary Text S-1</ext-link>).<sup><xref ref-type="bibr" rid="ref33">33</xref>,<xref ref-type="bibr" rid="ref53">53</xref>&#x02212;<xref ref-type="bibr" rid="ref57">57</xref></sup></p><fig id="fig1" position="float"><label>Figure 1</label><caption><p><italic>Viola tricolor</italic> cyclotide precursor analysis. (A)
A generic cyclotide precursor is ribosomally synthesized and contains
an ER signal, followed by a N-pro-region, N-terminal repeats (NTR),
the cyclotide domain, and a C-terminal tail region. Cyclotide precursors
may encode up to three peptide domains as it has been demonstrated
for the <italic>V. tricolor</italic> tricyclon A precursor. Novel
vitri precursors discovered by transcriptome mining contain one, two,
or three cyclotide domains. Exemplarily shown are vitri precursors
2 and 9. As indicated each precursor domain may vary in length. For
instance, vitri precursor 24 comprises an extended C-tail, whereas
vitri precursor 52 completely lacks this domain. (B) Sequence comparison
of vitri precursor processing site has been provided by a sequence
logo. Three adjacent residues downstream of the C-terminus of the
mature cyclotide domain in positions P&#x02032;1, P&#x02032;2, and P&#x02032;3,
and upstream of the N-terminus of the mature cyclotide domain in positions
P1, P2, and P3 have been considered for being essential for precursor
processing and cyclization <italic>in planta</italic>. Loop six comprises
the highly conserved ligation sites, namely, glycine and asparagine
or aspartic acid as highlighted in green.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr-2015-006814_0002" id="gr1" position="float"/></fig><p>These novel vitri precursor sequences encode up to 108 putative
cyclotides of <italic>V. tricolor</italic>, and many of them exhibit
novel or very rare features (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5b00681/suppl_file/pr5b00681_si_001.pdf">Supplementary Table S-1</ext-link>). They have been discussed in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5b00681/suppl_file/pr5b00681_si_001.pdf">Supporting Information</ext-link> as extended discussion of the sequence information
provided by the presented transcriptome analysis (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5b00681/suppl_file/pr5b00681_si_001.pdf">Supplementary Figure S-1, Supplementary Text S-1</ext-link>). These new
and rare sequence properties underline the structural plasticity of
cyclotides, and they may be of future interest for studies utilizing
cyclotides in peptide engineering and drug development.<sup><xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref9">9</xref></sup></p><p>Although transcriptome data analysis revealed 108 peptide sequences,
only a single known <italic>V. tricolor</italic> cyclotide (vitri
D) has been identified at the transcript level. Moreover, the reported
vitri precursor tricyclon precursor A could not be verified by transcriptome
mining.<sup><xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref49">49</xref></sup> It is known that cyclotide expression levels
appear to be strongly determined by environmental conditions or seasonal
changes.<sup><xref ref-type="bibr" rid="ref58">58</xref></sup> In fact, certain cyclotide precursors
are exclusively expressed in certain plant tissues,<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> and biotic and abiotic factors may influence cyclotide
transcription.<sup><xref ref-type="bibr" rid="ref60">60</xref>,<xref ref-type="bibr" rid="ref61">61</xref></sup> Most importantly, the major limitation
of <italic>in silico</italic> sequence mining is the erroneous prediction
of processing sites by homology, and hence certain cyclotides may
be assigned alternatively (see footnotes <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5b00681/suppl_file/pr5b00681_si_001.pdf">Supplementary Table S-1</ext-link>). Only peptide analysis at the proteome level using
MS will be able to verify and confirm the data obtained from transcriptome
analysis.</p></sec><sec id="sec3.2"><title>Analysis of Cyclotide Expression at Proteome Level</title><p>Having established a comprehensive view of the expression of cyclotide
peptides at the nucleic acid level, we were interested in cyclotides
present at the protein level. To elucidate the cyclotide proteome
of <italic>V. tricolor</italic> MS was used to collect evidence of
the expression of cyclotides in <italic>V. tricolor</italic>. Starting
with powdered herb material, hydrophobic compounds were extracted
and purified using well established protocols.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> This vitri extract was used as starting material for MS-based investigations.
Capillary liquid chromatography coupled to a QqTOF mass spectrometer
was used to record base peak chromatograms of all specimens in a signal
range between 800&#x02013;2200 Da (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>A). LC&#x02013;MS survey scans were evaluated
for putative cyclotide masses using deconvolution tools (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5b00681/suppl_file/pr5b00681_si_001.pdf">Supplementary Table S-2</ext-link>). LC&#x02013;MS resolved
126 peptide signals by the detection of the isotopic pattern, charge
state deconvolution, or both. Most notably, the LC&#x02013;MS system
takes advantage of its high resolution power by chromatographic separation
and hence in total higher capacity in the scan mode. In contrast MALDI&#x02212;TOF
MS analysis of vitri plant extract using the 4800 MS analyzer suffers
resolution problems due to multiple overlapping signals. This is why
MALDI&#x02212;MS only yielded 36 peptide signals (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>B). On the other hand, cO28
was only detected by MALDI&#x02212;MS, but not by LC&#x02013;MS, which
exemplifies sequence specific ionization differences. Among others,
LC&#x02013;MS revealed mass signals of vitri peptides kalata S, varv
peptide D, E, F, H, He, Hm, vitri A, D, E, F, tricyclon A and cycloviolacin
O2. Mass signals for vitri B, C and tricyclon B were not found with
either technique. Obviously the LC&#x02013;MS scan provided better
resolution, which resulted in a higher number of identified cyclotide
masses. Nevertheless, the combination of QqTOF and MALDI&#x02212;TOF
MS appeared to be more powerful for increasing the number of identified
cyclotides. To gain deeper insight into cyclotide diversity of <italic>V. tricolor</italic>, in particular with regard to molecular structure
and PTMs, we utilized MS-based peptide fragmentation and database
searching to identify cyclotides by an automated proteomics workflow.</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Mass spectrometry analysis of <italic>Viola tricolor</italic> cyclotide
extract. (A) Plant peptide extract from <italic>V. tricolor</italic> was analyzed via LC&#x02013;MS. A base peak chromatogram of mass
signals ranging from 800&#x02013;2200 Da is shown. Cyclotide masses
were found to carry +2, +3, and rarely +4 H-ions. Signals &#x0003e;5.0% intensity
threshold were assigned to mass and charge deconvolution tool from
Data Analysis software (Bruker Daltonics). The determined cyclotide
mass signals were consecutively numbered by increasing retention times.
(B) Accordingly a MALDI&#x02212;TOF spectrum is shown between 2750
and 3500 Da. Mass signals with an intensity threshold of &#x0003e;0.5% are
labeled. For cyclotide names, retention times and molecular weight
(monoisotopic masses) refer to <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5b00681/suppl_file/pr5b00681_si_001.pdf">Supplementary Table S-2</ext-link>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr-2015-006814_0003" id="gr2" position="float"/></fig></sec><sec id="sec3.3"><title>MS/MS Peptide Sequencing of Cyclotides</title><p>MS/MS fragmentation
data of vitri extract were recorded with a capillary LC-QqTOF instrument
and queried against the customized vitri database. For this purpose,
the existing ERA database<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> was updated
to contain all vitri precursors or mature peptide sequences that were
discovered by transcriptome mining (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5b00681/suppl_file/pr5b00681_si_001.pdf">Supplementary Table S-1 and Supplementary Data S-1</ext-link>). The lack of a C- or
N-terminus requires enzymatic processing for opening the cyclotide
backbone, and linearization facilitates sufficient fragmentation using
collision induced dissociation since intact cyclotides exhibit poor
fragmentation.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> The most advanced strategy
is to utilize a combination of multiple endopeptidases, i.e., trypsin
and endoproteinase Glu C.<sup><xref ref-type="bibr" rid="ref21">21</xref>,<xref ref-type="bibr" rid="ref36">36</xref></sup> This methodology resulted
in multiple precursor peptides for one cyclotide with significant
hits using the database analysis. <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref> summarizes cyclotides identified by proteomics
analysis of a vitri extract. Identification of a unique full or partial
sequence in at least one of the digested samples with a Mascot score
&#x0003e;50 was considered valid, and each cyclotide hit was further supported
by peptide identification using MALDI&#x02212;TOF or LC&#x02013;MS scans.
In total, 38 cyclotides were determined, 26 with full and 12 with
partial sequence coverage (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). Using this proteomics workflow, it was possible
to confirm the expression of vitri cyclotides varv peptide A, D, E,
F, H, vitri A, D, E, cycloviolacin O2 and tricyclon A.<sup><xref ref-type="bibr" rid="ref17">17</xref>,<xref ref-type="bibr" rid="ref50">50</xref></sup> Five cyclotides (vitri 18b, 22a, 39, 42a, and 94b) were detected
from the novel transcriptome data set, and tricyclon B as well as
oak6 cyclotide 1 were verified at protein level for the first time.<sup><xref ref-type="bibr" rid="ref49">49</xref>,<xref ref-type="bibr" rid="ref60">60</xref></sup> Further, this methodology yielded identification of the cyclotides
cO13, cO22, and cO28, kalata B1, varv peptide B, C and G, vigno 4
and 5, viba 30 and 32, vodo M, vodo N.</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>Identification and Discovery of Vitri
Cyclotides by LC&#x02212;MS/MS Peptide Sequencing of <italic>Viola
tricolor</italic> Extract and Fractions</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="char" char="."/><col align="center"/><col align="center"/><col align="center"/><col align="char" char="."/><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">name</th><th style="border:none;" align="center">sequence</th><th style="border:none;" align="center" char=".">calc mass
(monoiso.) [Da]</th><th style="border:none;" align="center">LC-MS</th><th style="border:none;" align="center">MALDI-MS</th><th style="border:none;" align="center">transcriptome</th><th style="border:none;" align="center" char=".">Mascot score<xref rid="t1fn4" ref-type="table-fn">d</xref></th><th style="border:none;" align="center">full/partial
sequence</th><th style="border:none;" align="center">PTM<xref rid="t1fn5" ref-type="table-fn">e</xref></th></tr></thead><tbody><tr><td style="border:none;" align="left">cycloviolacin O2</td><td style="border:none;" align="left">GIPCGESCVWIPCISSAIGCSCKSKVCYRN</td><td style="border:none;" align="char" char=".">3138.37</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">104.9</td><td style="border:none;" align="left">partial<xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ)</td></tr><tr><td style="border:none;" align="left">cO4</td><td style="border:none;" align="left">GIPCGESCVWIPCISSAIGCSCKNKVCYRN</td><td style="border:none;" align="char" char=".">3165.38</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">113.3</td><td style="border:none;" align="left">full<xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ)</td></tr><tr><td style="border:none;" align="left">cO13</td><td style="border:none;" align="left">GIPCGESCVWIPCISAAIGCSCKSKVCYRN</td><td style="border:none;" align="char" char=".">3122.37</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">91.6</td><td style="border:none;" align="left">partial<xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ)</td></tr><tr><td style="border:none;" align="left">cO20</td><td style="border:none;" align="left">GIPCGESCVWIPCLTSAIGCSCKSKVCYRD</td><td style="border:none;" align="char" char=".">3153.37</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">90.2</td><td style="border:none;" align="left">partial<xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">cO22</td><td style="border:none;" align="left">GLPICGETCVGGTCNTPGCTCSWPVCTRN</td><td style="border:none;" align="char" char=".">2904.16</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">118.8</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ), Hkyn(W),</td></tr><tr><td style="border:none;" align="left">cO22 (linear)</td><td style="border:none;" align="left">acyclo-GLPICGETCVGGTCNTPGCTCSWPVCTRN</td><td style="border:none;" align="char" char=".">2922.16</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">93.7</td><td style="border:none;" align="left">partial<xref rid="t1fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">cO28</td><td style="border:none;" align="left">GLPVCGETCVGGTCNTPGCSCSWPVCFRD</td><td style="border:none;" align="char" char=".">2923.13</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">103.3</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">Methyl (D)</td></tr><tr><td style="border:none;" align="left">chacur&#x000a0;1</td><td style="border:none;" align="left">GLPVCGETCVGGTCNTPGCTCSWPICTRN</td><td style="border:none;" align="char" char=".">2904.16</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">76.8</td><td style="border:none;" align="left">partial<xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Hkyn(W)</td></tr><tr><td style="border:none;" align="left">vitri peptide&#x000a0;1</td><td style="border:none;" align="left">GLIPCGESCVWIPCISSVIGCSCKSKVCYKN</td><td style="border:none;" align="char" char=".">3251.48</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">58.2</td><td style="border:none;" align="left">partial<xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vitri peptide&#x000a0;2</td><td style="border:none;" align="left">GSIPCGESCVWIPCISGIAGCSCSNKVCYLN</td><td style="border:none;" align="char" char=".">3138.32</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">63.4</td><td style="border:none;" align="left">partial<xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vitri peptide&#x000a0;3</td><td style="border:none;" align="left">GSWPCGESCVYIPCITSIAGCECSKNVCYKN</td><td style="border:none;" align="char" char=".">3289.35</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">86.8</td><td style="border:none;" align="left">partial<xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vitri peptide&#x000a0;4</td><td style="border:none;" align="left">GTPCGESCIYVPCISAVFGCWCQSKVCYKD</td><td style="border:none;" align="char" char=".">3221.32</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">74.3</td><td style="border:none;" align="left">partial<xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vitri peptide&#x000a0;8 (linear)</td><td style="border:none;" align="left">acyclo-PTPCGETCIWISCVTAAIGCYCHESICYR</td><td style="border:none;" align="char" char=".">3172.31</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">91.4</td><td style="border:none;" align="left">partial<xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vitri peptide&#x000a0;9<italic>a</italic>/53</td><td style="border:none;" align="left">acyclo-GTIFDCGETCLLGKCYTPGCSCGSWALCYGQN</td><td style="border:none;" align="char" char=".">3343.11</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">106.4</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vitri peptide&#x000a0;14</td><td style="border:none;" align="left">GSSCGETCEVFSCFITRCACIDGLCYRN</td><td style="border:none;" align="char" char=".">3012.18</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">62.0</td><td style="border:none;" align="left">partial<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vitri peptide&#x000a0;17</td><td style="border:none;" align="left">GSDDQVACGESCAMTPCFMHVVGCVCSQKVCYR</td><td style="border:none;" align="char" char=".">3488.37</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">81.5</td><td style="border:none;" align="left">partial<xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Ox (M)</td></tr><tr><td style="border:none;" align="left">vitri peptide&#x000a0;18a</td><td style="border:none;" align="left">GVPICGETCFQGTCNTPGCTCKWPICERN</td><td style="border:none;" align="char" char=".">3092.25</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">121.1</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ), Methyl (D)</td></tr><tr><td style="border:none;" align="left">vitri peptide&#x000a0;20</td><td style="border:none;" align="left">GDLVPCGESCVYIPCLTTVLGCSCSENVCYRN</td><td style="border:none;" align="char" char=".">3372.41</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">71.1</td><td style="border:none;" align="left">partial<xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vitri peptide&#x000a0;21</td><td style="border:none;" align="left">GGPLDCQETCTLSDRCYTKGCTCNWPICYKN</td><td style="border:none;" align="char" char=".">3447.39</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">60.2</td><td style="border:none;" align="left">partial<xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vitri peptide&#x000a0;22a</td><td style="border:none;" align="left">GAPVCGETCFTGLCYSSGCSCIYPVCNRN</td><td style="border:none;" align="char" char=".">2979.16</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">153.0</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ)</td></tr><tr><td style="border:none;" align="left">vitri peptide&#x000a0;22a (linear)</td><td style="border:none;" align="left">acyclo-GAPVCGETCFTGLCYSSGCSCIYPVCNRN</td><td style="border:none;" align="char" char=".">2997.16</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">75.9</td><td style="border:none;" align="left">partial<xref rid="t1fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vitri peptide&#x000a0;94b</td><td style="border:none;" align="left">GVAVCGETCTLGTCYTPGCSCDWPICKRN</td><td style="border:none;" align="char" char=".">3012.22</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">139.0</td><td style="border:none;" align="left">partial<xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Hkyn(W), Methyl (D)</td></tr><tr><td style="border:none;" align="left">vitri peptide&#x000a0;23</td><td style="border:none;" align="left">GLPTCGETCTLGTCYTPGCTCSWPLCTKN</td><td style="border:none;" align="char" char=".">2985.19</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">53.8</td><td style="border:none;" align="left">partial<xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vitri peptide 24/28</td><td style="border:none;" align="left">GEPVCGDSCVFFGCDDEGCTCGPWSLCYRN</td><td style="border:none;" align="char" char=".">3194.14</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">57.9</td><td style="border:none;" align="left">partial<xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vitri peptide&#x000a0;27a</td><td style="border:none;" align="left">GAFTPCGETCLTGECHTEGCSCVGQTFCVKK</td><td style="border:none;" align="char" char=".">3171.27</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">67.0</td><td style="border:none;" align="left">partial<xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ)</td></tr><tr><td style="border:none;" align="left">vitri peptide&#x000a0;29</td><td style="border:none;" align="left">GVPSSDCLETCFGGKCNAHRCTCSQWPLCAKN</td><td style="border:none;" align="char" char=".">3390.39</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">158.8</td><td style="border:none;" align="left">partial<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vitri peptide&#x000a0;30</td><td style="border:none;" align="left">GFACGETCIFTSCFITGCTCNSSLCFRN</td><td style="border:none;" align="char" char=".">2960.15</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">86.6</td><td style="border:none;" align="left">partial<xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vitri peptide 36/37</td><td style="border:none;" align="left">GGTIFSCGESCFQGTCYTKGCACGDWKLCYGEN</td><td style="border:none;" align="char" char=".">3463.32</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">101.9</td><td style="border:none;" align="left">partial<xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left">Dea (NQ)</td></tr><tr><td style="border:none;" align="left">vitri peptide&#x000a0;38</td><td style="border:none;" align="left">GDTCYETCFTGFCFIGGCKCDFPVCVKN</td><td style="border:none;" align="char" char=".">3032.18</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">63.0</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vitri peptide&#x000a0;39</td><td style="border:none;" align="left">GAPICGESCFTGTCYTVQCSCSWPVCTRN</td><td style="border:none;" align="char" char=".">3048.18</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">207.0</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ)</td></tr><tr><td style="border:none;" align="left">vitri peptide&#x000a0;39 (linear)</td><td style="border:none;" align="left">acyclo-GAPICGESCFTGTCYTVQCSCSWPVCTRN</td><td style="border:none;" align="char" char=".">3066.18</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">n.a.</td><td style="border:none;" align="left">partial<xref rid="t1fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vitri peptide&#x000a0;24a</td><td style="border:none;" align="left">GGTIFNCGESCFQGTCYTKGCACGDWKLCYGEN</td><td style="border:none;" align="char" char=".">3490.33</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">170.4</td><td style="border:none;" align="left">partial<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ), Ethyl (E)</td></tr><tr><td style="border:none;" align="left">vitri peptide&#x000a0;50</td><td style="border:none;" align="left">GDIPCGESCVYIPCITGVLGCSCSHNVCYYN</td><td style="border:none;" align="char" char=".">3244.29</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">76.9</td><td style="border:none;" align="left">full<xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ)</td></tr><tr><td style="border:none;" align="left">vitri peptide&#x000a0;18b</td><td style="border:none;" align="left">GSVFNCGETCVFGTCFTSGCSCVYRVCSKD</td><td style="border:none;" align="char" char=".">3134.26</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">163.8</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ)</td></tr><tr><td style="border:none;" align="left">kalata&#x000a0;B1</td><td style="border:none;" align="left">GLPVCGETCVGGTCNTPGCTCSWPVCTRN</td><td style="border:none;" align="char" char=".">2890.14</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">161.7</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ), Hkyn(W),</td></tr><tr><td style="border:none;" align="left">kalata&#x000a0;B1 (linear)</td><td style="border:none;" align="left">acyclo-GLPVCGETCVGGTCNTPGCTCSWPVCTRN</td><td style="border:none;" align="char" char=".">2908.14</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">n.a.</td><td style="border:none;" align="left">partial<xref rid="t1fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">kalata&#x000a0;S</td><td style="border:none;" align="left">GLPVCGETCVGGTCNTPGCSCSWPVCTRN</td><td style="border:none;" align="char" char=".">2876.13</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">307.0</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ), Hkyn(W),</td></tr><tr><td style="border:none;" align="left">kalata&#x000a0;S (linear)</td><td style="border:none;" align="left">acyclo-GLPVCGETCVGGTCNTPGCSCSWPVCTRN</td><td style="border:none;" align="char" char=".">2894.13</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">n.a.</td><td style="border:none;" align="left">partial<xref rid="t1fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">mram&#x000a0;8</td><td style="border:none;" align="left">GIPCGESCVFIPCLTSAIGCSCKSKVCYRN</td><td style="border:none;" align="char" char=".">3113.37</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">100.2</td><td style="border:none;" align="left">partial<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">oak6 cyclotide&#x000a0;1</td><td style="border:none;" align="left">GLPVCGETCFGGTCNTPGCACDPWPVCTRN</td><td style="border:none;" align="char" char=".">3033.18</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">75.4</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left">Hkyn(W), Dea (NQ)</td></tr><tr><td style="border:none;" align="left">tricyclon&#x000a0;A</td><td style="border:none;" align="left">GGTIFDCGESCFLGTCYTKGCSCGEWKLCYGTN</td><td style="border:none;" align="char" char=".">3478.35</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">331.3</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ)</td></tr><tr><td style="border:none;" align="left">tricyclon&#x000a0;A (linear)</td><td style="border:none;" align="left">acyclo-GTIFDCGESCFLGTCYTKGCSCGEWKLCYGTN</td><td style="border:none;" align="char" char=".">3496.35</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">n.a.</td><td style="border:none;" align="left">partial<xref rid="t1fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">Dea (NQ)</td></tr><tr><td style="border:none;" align="left">tricyclon&#x000a0;B</td><td style="border:none;" align="left">GGTIFDCGESCFLGTCYTKGCSCGEWKLCYGEN</td><td style="border:none;" align="char" char=".">3506.35</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">200.0</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ), Ethyl (E)</td></tr><tr><td style="border:none;" align="left">vaby&#x000a0;C</td><td style="border:none;" align="left">GLPVCGETCAGGRCNTPGCSCSWPVCTRN</td><td style="border:none;" align="char" char=".">2903.15</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">122.6</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vaby&#x000a0;E</td><td style="border:none;" align="left">GLPVCGETCFGGTCNTPGCSCDPWPVCTRN</td><td style="border:none;" align="char" char=".">3049.17</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">91.9</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left">Dea (NQ)</td></tr><tr><td style="border:none;" align="left">varv peptide&#x000a0;E/vigno&#x000a0;3 (linear)</td><td style="border:none;" align="left">acycloGLPLCGETCVGGTCNTPGCSCSWPVCTRN</td><td style="border:none;" align="char" char=".">2908.15</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">n.a.</td><td style="border:none;" align="left">partial<xref rid="t1fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">varv&#x000a0;B</td><td style="border:none;" align="left">GLPVCGETCFGGTCNTPGCSCDPWPMCSRN</td><td style="border:none;" align="char" char=".">3067.13</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">229.0</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Me(Ox), Dea (NQ)</td></tr><tr><td style="border:none;" align="left">varv&#x000a0;B (linear)</td><td style="border:none;" align="left">acyclo-GLPVCGETCFGGTCNTPGCSCDPWPMCSRN</td><td style="border:none;" align="char" char=".">3085.13</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">77.4</td><td style="border:none;" align="left">partial<xref rid="t1fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">Ox (M)</td></tr><tr><td style="border:none;" align="left">varv&#x000a0;C</td><td style="border:none;" align="left">GVPICGETCVGGTCNTPGCSCSWPVCTRN</td><td style="border:none;" align="char" char=".">2876.13</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">253.7</td><td style="border:none;" align="left">full<xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ)</td></tr><tr><td style="border:none;" align="left">varv&#x000a0;C (linear)</td><td style="border:none;" align="left">acyclo-GVPICGETCVGGTCNTPGCSCSWPVCTRN</td><td style="border:none;" align="char" char=".">2894.13</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">n.a.</td><td style="border:none;" align="left">partial<xref rid="t1fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">varv&#x000a0;D</td><td style="border:none;" align="left">GLPICGETCVGGSCNTPGCSCSWPVCTRN</td><td style="border:none;" align="char" char=".">2876.13</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">189</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ)</td></tr><tr><td style="border:none;" align="left">varv&#x000a0;D (linear)</td><td style="border:none;" align="left">acyclo-GLPICGETCVGGSCNTPGCSCSWPVCTRN</td><td style="border:none;" align="char" char=".">2894.13</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">50.1</td><td style="border:none;" align="left">partial<xref rid="t1fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">Hkyn(W),</td></tr><tr><td style="border:none;" align="left">varv&#x000a0;E/vigno&#x000a0;3</td><td style="border:none;" align="left">GLPICGETCVGGTCNTPGCSCSWPVCTRN</td><td style="border:none;" align="char" char=".">2890.14</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">251.3</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ), Hkyn(W),</td></tr><tr><td style="border:none;" align="left">varv&#x000a0;F</td><td style="border:none;" align="left">GVPICGETCTLGTCYTAGCSCSWPVCTRN</td><td style="border:none;" align="char" char=".">2957.17</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">244.5</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ), Hkyn(W)</td></tr><tr><td style="border:none;" align="left">varv&#x000a0;F (linear)</td><td style="border:none;" align="left">acyclo-GVPICGETCTLGTCYTAGCSCSWPVCTRN</td><td style="border:none;" align="char" char=".">2975.37</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">n.a.</td><td style="border:none;" align="left">partial<xref rid="t1fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">varv&#x000a0;G</td><td style="border:none;" align="left">GVPVCGETCFGGTCNTPGCSCDPWPVCSRN</td><td style="border:none;" align="char" char=".">3021.14</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">211.8</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ), Hkyn(W),</td></tr><tr><td style="border:none;" align="left">varv&#x000a0;G (linear)</td><td style="border:none;" align="left">acyclo-GVPVCGETCFGGTCNTPGCSCDPWPVCSRN</td><td style="border:none;" align="char" char=".">3039.14</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">n.a.</td><td style="border:none;" align="left">partial<xref rid="t1fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">varv&#x000a0;H</td><td style="border:none;" align="left">GLPVCGETCFGGTCNTPGCSCETWPVCSRN</td><td style="border:none;" align="char" char=".">3053.17</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">151.1</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ), Ethyl (E), Methyl
(D)</td></tr><tr><td style="border:none;" align="left">viba&#x000a0;11</td><td style="border:none;" align="left">GIPCGESCVWIPCISGAIGCSCKSKVCYRN</td><td style="border:none;" align="char" char=".">3108.36</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">60.8</td><td style="border:none;" align="left">full<xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ)</td></tr><tr><td style="border:none;" align="left">viba&#x000a0;15</td><td style="border:none;" align="left">GLPVCGETCVGGTCNTPGCACSWPVCTRN</td><td style="border:none;" align="char" char=".">2880.13</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">99.7</td><td style="border:none;" align="left">full<xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Hkyn(W), Dea (NQ)</td></tr><tr><td style="border:none;" align="left">viba&#x000a0;19</td><td style="border:none;" align="left">GLPVCGETCFGGTCNTPGCSCEWPVCTRN</td><td style="border:none;" align="char" char=".">2966.14</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">77.3</td><td style="border:none;" align="left">partial<xref rid="t1fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">Dea (NQ)</td></tr><tr><td style="border:none;" align="left">viba&#x000a0;30</td><td style="border:none;" align="left">GPPVCGETCVGGTCNTPGCSCSWPVCTRN</td><td style="border:none;" align="char" char=".">2860.10</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">191.0</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ), Kyn(W),</td></tr><tr><td style="border:none;" align="left">viba&#x000a0;30 (linear)</td><td style="border:none;" align="left">acyclo-GPPVCGETCVGGTCNTPGCSCSWPVCTRN</td><td style="border:none;" align="char" char=".">2878.10</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">n.a.</td><td style="border:none;" align="left">partial<xref rid="t1fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">viba&#x000a0;32</td><td style="border:none;" align="left">GLPVCGEACVGGTCNTPGCSCSWPVCTRN</td><td style="border:none;" align="char" char=".">2846.12</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">110.9</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ), Ethyl (E)</td></tr><tr><td style="border:none;" align="left">viba&#x000a0;9</td><td style="border:none;" align="left">GIPCGESCVWIPCISSAIGCSCKNKVCYRK</td><td style="border:none;" align="char" char=".">3179.43</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">106.5</td><td style="border:none;" align="left">full<xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vibi&#x000a0;C</td><td style="border:none;" align="left">GLPVCGETCAFGSCYTPGCSCSWPVCTRN</td><td style="border:none;" align="char" char=".">2973.15</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">52.8</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vibi&#x000a0;G</td><td style="border:none;" align="left">GTFPCGESCVFIPCLTSAIGCSCKSKVCYKN</td><td style="border:none;" align="char" char=".">3220.40</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">74.1</td><td style="border:none;" align="left">partial<xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vigno&#x000a0;10</td><td style="border:none;" align="left">GTIPCGESCVWIPCISSVVGCSCKSKVCYKD</td><td style="border:none;" align="char" char=".">3226.41</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">68.9</td><td style="border:none;" align="left">partial<xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ)</td></tr><tr><td style="border:none;" align="left">vigno&#x000a0;4</td><td style="border:none;" align="left">GLPLCGETCVGGTCNTPACSCSWPVCTRN</td><td style="border:none;" align="char" char=".">2904.16</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">141.7</td><td style="border:none;" align="left">full<xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ), Hkyn(W),</td></tr><tr><td style="border:none;" align="left">vigno&#x000a0;5</td><td style="border:none;" align="left">GLPLCGETCVGGTCNTPGCSCGWPVCVRN</td><td style="border:none;" align="char" char=".">2858.15</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">152.2</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vigno&#x000a0;5 (linear)</td><td style="border:none;" align="left">acyclo-GLPLCGETCVGGTCNTPGCSCGWPVCVRN</td><td style="border:none;" align="char" char=".">2876.20</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">152.3</td><td style="border:none;" align="left">full<xref rid="t1fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vigno&#x000a0;6</td><td style="border:none;" align="left">GIPCGESCVWIPCISSAIGCSCKGSKVCYRN</td><td style="border:none;" align="char" char=".">3195.39</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">78.8</td><td style="border:none;" align="left">partial<xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vigno&#x000a0;7</td><td style="border:none;" align="left">GTLPCGESCVWIPCISSVVGCSCKNKVCYKN</td><td style="border:none;" align="char" char=".">3252.44</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">72.3</td><td style="border:none;" align="left">partial<xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ)</td></tr><tr><td style="border:none;" align="left">vigno&#x000a0;9</td><td style="border:none;" align="left">GIPCGESCVWIPCISSALGCSCKSKVCYRN</td><td style="border:none;" align="char" char=".">3138.37</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">90.8</td><td style="border:none;" align="left">partial<xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vitri&#x000a0;A/cO3</td><td style="border:none;" align="left">GIPCGESCVWIPCLTSAIGCSCKSKVCYRN</td><td style="border:none;" align="char" char=".">3152.38</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">93.6</td><td style="border:none;" align="left">partial<xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ)</td></tr><tr><td style="border:none;" align="left">vitri&#x000a0;D</td><td style="border:none;" align="left">GLPVCGETCFTGSCYTPGCSCNWPVCNRN</td><td style="border:none;" align="char" char=".">3043.16</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="char" char=".">69.6</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vitri&#x000a0;E</td><td style="border:none;" align="left">GLPVCGETCVGGTCNTPGCSCSWPVCFRN</td><td style="border:none;" align="char" char=".">2922.15</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">192.9</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ)</td></tr><tr><td style="border:none;" align="left">vitri&#x000a0;E (linear)</td><td style="border:none;" align="left">acyclo-GLPVCGETCVGGTCNTPGCSCSWPVCFRN</td><td style="border:none;" align="char" char=".">2940.13</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">n.a.</td><td style="border:none;" align="left">partial<xref rid="t1fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vitri&#x000a0;F</td><td style="border:none;" align="left">GLTPCGESCVWIPCISSVVGCACKSKVCYKD</td><td style="border:none;" align="char" char=".">3210.41</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">67.3</td><td style="border:none;" align="left">partial<xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vodo&#x000a0;M</td><td style="border:none;" align="left">GAPICGESCFTGKCYTVQCSCSWPVCTRN</td><td style="border:none;" align="char" char=".">3075.23</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">162.8</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">vodo&#x000a0;N</td><td style="border:none;" align="left">GLPVCGETCTLGKCYTAGCSCSWPVCYRN</td><td style="border:none;" align="char" char=".">3046.24</td><td style="border:none;" align="center">x</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">201.4</td><td style="border:none;" align="left">full<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">Dea (NQ)</td></tr><tr><td style="border:none;" align="left">vodo&#x000a0;N (linear)</td><td style="border:none;" align="left">acyclo-GLPVCGETCTLGKCYTAGCSCSWPVCYRN</td><td style="border:none;" align="char" char=".">3066.24</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="center">&#x000a0;</td><td style="border:none;" align="char" char=".">n.a.</td><td style="border:none;" align="left">partial<xref rid="t1fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn id="t1fn1"><label>a</label><p>Identified in trypsin digest.</p></fn><fn id="t1fn2"><label>b</label><p>Identified in endoproteinase GluC
digest.</p></fn><fn id="t1fn3"><label>c</label><p>Identified in trypsin/endoproteinase
GluC double digest.</p></fn><fn id="t1fn4"><label>d</label><p>Best score out of two independent
analysis of each of the three digest experiments.</p></fn><fn id="t1fn5"><label>e</label><p>Modifications recorded in at least
one peptide of assigned peptides of in total six independent analysis.</p></fn></table-wrap-foot></table-wrap><p>One advantage of using an automated proteomics workflow is the
possibility to determine PTMs. In fact certain cyclotide modifications
have been previously reported.<sup><xref ref-type="bibr" rid="ref39">39</xref>,<xref ref-type="bibr" rid="ref42">42</xref>,<xref ref-type="bibr" rid="ref50">50</xref>&#x02212;<xref ref-type="bibr" rid="ref52">52</xref>,<xref ref-type="bibr" rid="ref62">62</xref></sup> It was possible to
confirm many of them occur in cyclotides from <italic>V. tricolor</italic>. The most commonly observed modifications of vitri cyclotides have
been illustrated, such as aspartate methylation, glutamate ethylation,
tryptophan oxidation to kynurenine and 3-hydroxykynurenine, as well
as deamidation of asparagine and glutamine (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A&#x02013;D). It is noteworthy that some peptides
differ only by one pivotal residue, for instance, vitri E (N29) and
cycloviolacin O28 (D29). In this case deamidation of the N29 residue
of vitri E would yield cycloviolacin O28 with a D29 residue. Judging
from the MS/MS data, both cyclotides were found side-by-side in <italic>V. tricolor</italic>, but nevertheless it was necessary to manually
reanalyze the automated assignments. Besides identification of common
PTMs of amino acid side chains, proteomics is a powerful tool to determine
cyclization of the N- and C-termini. Analysis of endoproteinase GluC
digested samples revealed evidence for the presence of acyclic peptides
in <italic>V. tricolor</italic>, namely, acyclo-kalata S, -tricyclon
A, -vigno 5 -viba 30, -varv peptide C, D, and E and -viba 30. Here,
the peptides from the C-terminal end to the first cleavage site of
the protease served as indicative fragments (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref> and <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>E). The acyclic peptide species have been additionally
confirmed by MS/MS analysis of reduced and alkylated samples. Since
cyclized peptides emerge stabilized during collision-induced dissociation,
only linear peptide species yielded MS/MS spectra with sufficient
fragmentation for database searching.</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Evaluation of post-translational modifications in cyclotides identified
by MS/MS sequencing and database analysis. Database searching of MS/MS
spectra of cyclotides revealed a number of peptides with posttranslational
modifications. The most abundant ones have been illustrated exemplarily:
(A) Aspartate methylation in vitri peptide 94b; (B) tryptophan degradation
product kynurenine in varv peptide E; (C) tryptophan oxidation to
3-hydroxy-tryptophan in kalata B1; and (D) glutamate ethylation and
glutamine or asparagine deamidation in vitri peptide 42a. (E) The
MS/MS fragment spectrum of a C-terminal fragment of endoproteinase
GluC processed vitri peptide 22a has been shown to confirm the presence
of acyclic cyclotides in <italic>V. tricolor</italic>. The major b-
and y-ion series have been labeled in all spectra. Furthermore, peptide
mass, cleavage protease, mass error, and Mascot score of the illustrated
peptides have been provided.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr-2015-006814_0004" id="gr3" position="float"/></fig><p>Although cyclotide sequencing in nonfractionated vitri plant extract
using the automated proteomics workflow yielded several known and
novel cyclotides, many peptides lacked identification by sequence,
as compared to analysis by molecular weight (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). Thus, to maximize the number of identified
cyclotides by sequence we introduced an HPLC-assisted fractionation
approach with the aim to enrich cyclotides in a particular fraction
and subsequently increase sensitivity of the proteomics workflow compared
to the extract starting material.</p></sec><sec id="sec3.4"><title>Fractionation-Based Enrichment Approach</title><p>The vitri extract
was subjected to preparative HPLC, and nine fractions were collected
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5b00681/suppl_file/pr5b00681_si_001.pdf">Supplementary Figure S-2</ext-link>). Each fraction
was evaluated for cyclotide masses by MALDI&#x02212;MS (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5b00681/suppl_file/pr5b00681_si_001.pdf">Supplementary Figure S-3</ext-link>). <italic>V. tricolor</italic> fraction F1 (vitri-F1) contained only minor amounts of cyclotide
masses in the range of 2500&#x02013;4500 Da, and vitri-F2 did not show
any cyclotide-related signals. Instead, analysis of vitri-F3&#x02013;F9
yielded significantly more molecular weight signals as compared to
MALDI&#x02212;TOF MS of nonfractionated vitri extract. According to
previous studies, fractionation has been confirmed as an efficient
tool for enrichment and increased identification of cyclotides.<sup><xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref63">63</xref></sup> The digested samples of each HPLC fraction were applied to LC&#x02013;MS/MS
sequencing. The results of the proteomics study of the vitri fractions
have been summarized in <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>. As compared to analysis of the vitri extract, overall 82
peptides have been validated by proteomics of the fractionated samples.
Most notable, 20 novel vitri peptides (1, 2, 3, 4, 8, 9<italic>a</italic>/53, 14, 17, 18a, 20, 21, 23, 24/28, 27a, 29, 30, 36/37, 38, 42a,
50) have been unambiguously characterized by MS/MS sequencing. In
addition, vitri F, cycloviolacin O4 and O20, chacur 1, vaby C, E,
viba 9, 11, 15, 19 vibi C, G, and vigno 6, 7, 9, and 10 have all been
validated and identified by the proteomics approach. Moreover, an
additional 11 acyclic peptides have been found as compared to the
analysis of the vitri extract; these were acyclo-kalata B1, -varv
peptide B, -F, -G, -vitri E, -vodo N, -vitri peptide 8, 9<italic>a</italic>/53, 22a, 39 and -cycloviolacin O22. Most acyclic peptides were found
alongside the cyclic species, except for vitri 8 of which only the
acyclic peptide has been identified. In fact, vitri precursor 8 encoding
for vitri 8 is missing the essential C-tail for successful cyclization <italic>in planta</italic>. In summary, sample enrichment by HPLC fractionation
is very effective to enhance the number of total cyclotides identified
by about 2-fold. Using proteomics provided evidence for 82 cyclotides
present at the protein level.</p></sec><sec id="sec3.5"><title>Comparison of Cyclotide Discovery Approaches</title><p>Cyclotide
analysis is associated with challenges regardless if they are studied
at the nucleic acid or proteome level. To highlight the benefits and
drawbacks of each method, it may be useful to compare the results,
i.e. the number of identified cyclotides, from transcriptome mining,
mass deconvolution, and MS/MS sequencing (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A). Analyzing cyclotides at the transcript
level, by mass signals deconvolution or by MS/MS sequencing 108, 127,
and 82 cyclotides were detected, respectively. Essentially, 54 cyclotides
were identified by MS/MS sequencing as well as mass deconvolution,
31 by MS/MS as well as transcriptome analysis, and 17 were found by
both mass deconvolution and transcriptome mining; 11 peptides were
identified by all three methods. After all, 28% of 108 vitri cyclotides
identified by transcriptome mining were confirmed by MS/MS or molecular
weight; 50% of cyclotides were assigned from partial sequences, 2%
constitute cyclotide-like peptides, and only 20% of all full-length
cyclotides determined by transcriptome mining remained unverified
by MS (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>B).
Considering full-length precursor molecules, 46% of all predicted
peptides were found by MS/MS sequencing. Importantly, 12 out of 14
previously published vitri peptides have been identified by MS/MS
sequence, which confirms the effectiveness of our approach, considering
that we worked with plant extracts and fractions but avoided using
purified cyclotides for proteomics analysis.</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>Comparative analysis of vitri cyclotides identified by transcriptome
mining, mass deconvolution, and MS/MS sequencing. (A) An overview
of vitri peptides discovered in this study is summarized by a Venn
diagram. The number of identified cyclotides by each approach (transcriptome
mining, mass deconvolution or MS/MS sequencing) is indicated by the
numbers in each of the three interwheeling circles. The overlapping
regions represent the numbers of identified cyclotides by combination
of two or all three approaches. (B) A pie chart illustrates coverage
for confirmation of predicted vitri cyclotides by MS. All predicted
108 vitri cyclotides identified by transcriptome mining were grouped
in cohorts: (i) confirmed by sequence or molecular weight (28%), (ii)
partial sequences from transcriptome mining (50%), (iii) cyclotide-like
molecules (2%) and unverified full-length cyclotides (20%).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr-2015-006814_0005" id="gr4" position="float"/></fig><p>Clearly, analyzing cyclotides by molecular weight only is the most
error-prone method for unambiguous characterization of cyclotides.
Nevertheless, combined with transcriptome analysis, a simple MS run
may provide useful information about the diversity of cyclotides in
a given plant extract. Similarly, transcriptome mining by itself resulted
in the identification of many novel cyclotides, but the sequences
of many vitri precursors contained uncommon C- or N-terminal processing
sites, such as the missing of the conserved asparagine or aspartic
acid residues or complete lack of C-tail motifs. In combination with
MS however, these powerful tools were able to verify some of these
peptides as acyclic cyclotide homologues (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5b00681/suppl_file/pr5b00681_si_001.pdf">Supplementary Table S-1</ext-link>). Obviously MS/MS sequencing using an automated proteomics
workflow appears to be the most effective approach for identifying
and characterizing novel cyclotides from <italic>V. tricolor</italic>, since it is capable of providing evidence not only for the presence
of a cyclotide and further yields detailed information sequence and
PTMs. Thus, we are confident that our results may provide a proof-of-principle
and motivation for continued efforts in cyclotide discovery in many
plant families using a combined transcriptome and proteome analysis
workflow.</p></sec></sec><sec id="sec4"><title>Conclusion</title><p>The presented study combined cyclotide peptide analysis at both
the nucleic acid and the proteome level to obtain insights into the
diversity of circular cysteine-rich peptides of <italic>V. tricolor.</italic> It provides a comprehensive view of the transcription and on the
translation of plant cyclotides and to our knowledge the largest study
to date in the field of cyclotide discovery and characterization.
Our results may provide a guideline for future cyclotide discovery
projects combining transcriptome and proteome analysis. Here we were
able to shed light to the unexplored diversity of plant-derived cyclotides
within the <italic>Violaceae</italic> family, which comprises up to
31 genera and approximately 1000 species.<sup><xref ref-type="bibr" rid="ref64">64</xref></sup> Previously 10 cyclotides have been estimated as a realistic number
of peptides to be expressed per <italic>Viola</italic> species.<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> A more recent study determined that a single
species may express up to 53 peptides.<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> To date, 161 individual cyclotides are known in Violaceae, and in
total 922 cyclotides are published online in CyBase (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.cybase.org.au">www.cybase.org.au</uri>). Our finding that <italic>V. tricolor</italic> contains at least
164 different cyclotides significantly augments the number of cyclotides
present in Violaceae. Thus, we determined that violaceous plants may
indeed exhibit a much higher cyclotide diversity than earlier anticipated<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> and contain up to &#x0003e;150&#x0202f;000 individual
cyclotides. Similarly, other plant families such as Rubiaceae may
contain 150&#x0202f;000 cyclotides or more, determined by the number
of cyclotides per species and multiplied by the estimated number of
species known to express cyclotides.<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> This
simple calculation does not account for any peptide that may be ubiquitously
expressed in many species. In addition other plant families of Cucurbitaceae,
Fabaceae, Poaceae and Solanaceae also contain cyclotides. Encompassing
the diversity of <italic>V. tricolor</italic> as a natural library
of bioactive peptides, this commercially available medicinal herb
may be a suitable starting point for future bioactivity-guided screening
studies, and the presented methodology may provide a guideline for
cyclotide analytics combining transcriptome and proteome analysis.</p></sec></body><back><notes id="notes-3" notes-type="si"><title>Supporting Information Available</title><p>The Supporting Information
is available free of charge on the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org">ACS Publications website</ext-link> at DOI: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/abs/10.1021/acs.jproteome.5b00681">10.1021/acs.jproteome.5b00681</ext-link>.<list id="silist" list-type="simple"><list-item><p>Supplementary Figure S-1. Loop lengths of <italic>Viola
tricolor</italic> cyclotides. Supplementary Text S-1. Extended Discussion.
Supplementary Figure S-2. Fractionation of cyclotide extract by preparative
HPLC. Supplementary Figure S-3. MALDI&#x02212;TOF MS analysis of vitri
extract and fractions 1&#x02013;9. Supplementary Data S-1. Novel cyclotide
precursor sequences from <italic>Viola tricolor</italic>. Supplementary
Data S-2. Alignment of mature cyclotides and processing sites. Supplementary
Table S-2. LC&#x02212;MS deconvolution and MALDI&#x02212;TOF MS of vitri
extract (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5b00681/suppl_file/pr5b00681_si_001.pdf">PDF</ext-link>)</p></list-item><list-item><p>Supplementary Table S-1. Viola tricolor cyclotides discovered
by transcriptome mining (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5b00681/suppl_file/pr5b00681_si_002.xlsx">XLSX</ext-link>)</p></list-item></list></p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr5b00681_si_001.pdf"><caption><p>pr5b00681_si_001.pdf</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="sifile2"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr5b00681_si_002.xlsx"><caption><p>pr5b00681_si_002.xlsx</p></caption></media></supplementary-material></sec><notes id="notes-2" notes-type="funding-statement"><p>This work was
financially supported by the Austrian Science Fund (FWF P-24743).
C.W.G. is an ARC Future Fellow. J.K. received a UQ Postdoctoral Research
Fellowship. The 1000 Plants (1kp) initiative, led by G.K-S.W., is
funded by the Alberta Ministry of Innovation and Advanced Education,
Alberta Innovates Technology Futures (AITF), Innovates Centres of
Research Excellence (iCORE), Musea Ventures, BGI-Shenzhen and China
National Genebank (CNGB). The funders had no role in study design,
data collection and analysis, decision to publish, or preparation
of the manuscript.</p></notes><notes id="NOTES-d1644e3764-autogenerated" notes-type="conflict-of-interest"><p>The authors declare no
competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>The authors would like to thank M. Gold-Binder and J.H. Leebens-Mack
for technical assistance. Further we thank C. Gr&#x000fc;ndemann for
providing a photograph of <italic>Viola tricolor</italic>, courtesy
of Weleda AG, Schw&#x000e4;bisch-Gm&#x000fc;nd, Germany.</p></ack><glossary id="dl1"><def-list><title>Abbreviations</title><def-item><term>Vitri</term><def><p><italic>Viola tricolor</italic></p></def></def-item><def-item><term>CCK</term><def><p>cyclic cystine-knot</p></def></def-item><def-item><term>MS</term><def><p>mass spectrometry</p></def></def-item><def-item><term>FLAS</term><def><p>University of
Florida Herbarium</p></def></def-item><def-item><term>BLAST</term><def><p>Basic Local Assignment Search Tool</p></def></def-item><def-item><term>NMR</term><def><p>nuclear magnetic resonance</p></def></def-item><def-item><term>MS</term><def><p>mass spectrometry</p></def></def-item><def-item><term>PTM</term><def><p>post-translational modification</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Gruber</surname><given-names>C. W.</given-names></name>; <name><surname>Cemazar</surname><given-names>M.</given-names></name>; <name><surname>Anderson</surname><given-names>M. A.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>
<article-title>Insecticidal plant
cyclotides and related cystine knot toxins</article-title>. <source>Toxicon</source>
<year>2007</year>, <volume>49</volume>, <fpage>561</fpage>&#x02013;<lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2006.11.018</pub-id>.<pub-id pub-id-type="pmid">17224167</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Tam</surname><given-names>J. P.</given-names></name>; <name><surname>Lu</surname><given-names>Y. A.</given-names></name>; <name><surname>Yang</surname><given-names>J. L.</given-names></name>; <name><surname>Chiu</surname><given-names>K. W.</given-names></name>
<article-title>An unusual structural
motif of antimicrobial peptides containing end-to-end macrocycle and
cystine-knot disulfides</article-title>. <source>Proc. Natl. Acad. Sci.
U. S. A.</source>
<year>1999</year>, <volume>96</volume>, <fpage>8913</fpage>&#x02013;<lpage>8</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.16.8913</pub-id>.<pub-id pub-id-type="pmid">10430870</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Colgrave</surname><given-names>M. L.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>
<article-title>Thermal, chemical, and enzymatic stability of the cyclotide
kalata B1: the importance of the cyclic cystine knot</article-title>. <source>Biochemistry</source>
<year>2004</year>, <volume>43</volume>, <fpage>5965</fpage>&#x02013;<lpage>75</lpage><pub-id pub-id-type="doi">10.1021/bi049711q</pub-id>.<pub-id pub-id-type="pmid">15147180</pub-id></mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Northfield</surname><given-names>S. E.</given-names></name>; <name><surname>Wang</surname><given-names>C. K.</given-names></name>; <name><surname>Schroeder</surname><given-names>C. I.</given-names></name>; <name><surname>Durek</surname><given-names>T.</given-names></name>; <name><surname>Kan</surname><given-names>M. W.</given-names></name>; <name><surname>Swedberg</surname><given-names>J. E.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>
<article-title>Disulfide-rich macrocyclic peptides
as templates in drug design</article-title>. <source>Eur. J. Med. Chem.</source>
<year>2014</year>, <volume>77</volume>, <fpage>248</fpage>&#x02013;<lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2014.03.011</pub-id>.<pub-id pub-id-type="pmid">24650712</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Wang</surname><given-names>C. K.</given-names></name>; <name><surname>Gruber</surname><given-names>C. W.</given-names></name>; <name><surname>Cemazar</surname><given-names>M.</given-names></name>; <name><surname>Siatskas</surname><given-names>C.</given-names></name>; <name><surname>Tagore</surname><given-names>P.</given-names></name>; <name><surname>Payne</surname><given-names>N.</given-names></name>; <name><surname>Sun</surname><given-names>G.</given-names></name>; <name><surname>Wang</surname><given-names>S.</given-names></name>; <name><surname>Bernard</surname><given-names>C. C.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>
<article-title>Molecular grafting onto a stable framework yields novel
cyclic peptides for the treatment of multiple sclerosis</article-title>. <source>ACS Chem. Biol.</source>
<year>2014</year>, <volume>9</volume>, <fpage>156</fpage>&#x02013;<lpage>63</lpage><pub-id pub-id-type="doi">10.1021/cb400548s</pub-id>.<pub-id pub-id-type="pmid">24147816</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Koehbach</surname><given-names>J.</given-names></name>; <name><surname>O&#x02019;Brien</surname><given-names>M.</given-names></name>; <name><surname>Muttenthaler</surname><given-names>M.</given-names></name>; <name><surname>Miazzo</surname><given-names>M.</given-names></name>; <name><surname>Akcan</surname><given-names>M.</given-names></name>; <name><surname>Elliott</surname><given-names>A. G.</given-names></name>; <name><surname>Daly</surname><given-names>N. L.</given-names></name>; <name><surname>Harvey</surname><given-names>P. J.</given-names></name>; <name><surname>Arrowsmith</surname><given-names>S.</given-names></name>; <name><surname>Gunasekera</surname><given-names>S.</given-names></name>; <name><surname>Smith</surname><given-names>T. J.</given-names></name>; <name><surname>Wray</surname><given-names>S.</given-names></name>; <name><surname>Goransson</surname><given-names>U.</given-names></name>; <name><surname>Dawson</surname><given-names>P. E.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>; <name><surname>Freissmuth</surname><given-names>M.</given-names></name>; <name><surname>Gruber</surname><given-names>C. W.</given-names></name>
<article-title>Oxytocic plant cyclotides as templates for peptide
G protein-coupled receptor ligand design</article-title>. <source>Proc.
Natl. Acad. Sci. U. S. A.</source>
<year>2013</year>, <volume>110</volume>, <fpage>21183</fpage>&#x02013;<lpage>88</lpage><pub-id pub-id-type="doi">10.1073/pnas.1311183110</pub-id>.<pub-id pub-id-type="pmid">24248349</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Hellinger</surname><given-names>R.</given-names></name>; <name><surname>Koehbach</surname><given-names>J.</given-names></name>; <name><surname>Puigpinos</surname><given-names>A.</given-names></name>; <name><surname>Clark</surname><given-names>R. J.</given-names></name>; <name><surname>Tarrago</surname><given-names>T.</given-names></name>; <name><surname>Giralt</surname><given-names>E.</given-names></name>; <name><surname>Gruber</surname><given-names>C. W.</given-names></name>
<article-title>Inhibition of Human Prolyl Oligopeptidase
Activity by the Cyclotide Psysol 2 Isolated from Psychotria solitudinum</article-title>. <source>J. Nat. Prod.</source>
<year>2015</year>, <volume>78</volume>, <fpage>1073</fpage>&#x02013;<lpage>82</lpage><pub-id pub-id-type="doi">10.1021/np501061t</pub-id>.<pub-id pub-id-type="pmid">25894999</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Schroeder</surname><given-names>C. I.</given-names></name>; <name><surname>Swedberg</surname><given-names>J. E.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>
<article-title>Recent progress towards pharmaceutical
applications of disulfide-rich cyclic peptides</article-title>. <source>Curr. Protein Pept. Sci.</source>
<year>2013</year>, <volume>14</volume>, <fpage>532</fpage>&#x02013;<lpage>42</lpage><pub-id pub-id-type="doi">10.2174/13892037113149990069</pub-id>.<pub-id pub-id-type="pmid">23968348</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Thell</surname><given-names>K.</given-names></name>; <name><surname>Hellinger</surname><given-names>R.</given-names></name>; <name><surname>Schabbauer</surname><given-names>G.</given-names></name>; <name><surname>Gruber</surname><given-names>C. W.</given-names></name>
<article-title>Immunosuppressive
peptides and their therapeutic applications</article-title>. <source>Drug Discovery Today</source>
<year>2014</year>, <volume>19</volume>, <fpage>645</fpage>&#x02013;<lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.drudis.2013.12.002</pub-id>.<pub-id pub-id-type="pmid">24333193</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Grundemann</surname><given-names>C.</given-names></name>; <name><surname>Koehbach</surname><given-names>J.</given-names></name>; <name><surname>Huber</surname><given-names>R.</given-names></name>; <name><surname>Gruber</surname><given-names>C. W.</given-names></name>
<article-title>Do Plant Cyclotides
Have Potential As Immunosuppressant Peptides?</article-title>. <source>J. Nat. Prod.</source>
<year>2012</year>, <volume>75</volume>, <fpage>167</fpage>&#x02013;<lpage>174</lpage><pub-id pub-id-type="doi">10.1021/np200722w</pub-id>.<pub-id pub-id-type="pmid">22272797</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Burman</surname><given-names>R.</given-names></name>; <name><surname>Gunasekera</surname><given-names>S.</given-names></name>; <name><surname>Stromstedt</surname><given-names>A. A.</given-names></name>; <name><surname>Goransson</surname><given-names>U.</given-names></name>
<article-title>Chemistry
and biology of cyclotides: circular plant peptides outside the box</article-title>. <source>J. Nat. Prod.</source>
<year>2014</year>, <volume>77</volume>, <fpage>724</fpage>&#x02013;<lpage>36</lpage><pub-id pub-id-type="doi">10.1021/np401055j</pub-id>.<pub-id pub-id-type="pmid">24527877</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Gruber</surname><given-names>C. W.</given-names></name>; <name><surname>Elliott</surname><given-names>A. G.</given-names></name>; <name><surname>Ireland</surname><given-names>D. C.</given-names></name>; <name><surname>Delprete</surname><given-names>P. G.</given-names></name>; <name><surname>Dessein</surname><given-names>S.</given-names></name>; <name><surname>Goransson</surname><given-names>U.</given-names></name>; <name><surname>Trabi</surname><given-names>M.</given-names></name>; <name><surname>Wang</surname><given-names>C. K.</given-names></name>; <name><surname>Kinghorn</surname><given-names>A. B.</given-names></name>; <name><surname>Robbrecht</surname><given-names>E.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>
<article-title>Distribution and evolution of circular
miniproteins in flowering plants</article-title>. <source>Plant Cell</source>
<year>2008</year>, <volume>20</volume>, <fpage>2471</fpage>&#x02013;<lpage>83</lpage><pub-id pub-id-type="doi">10.1105/tpc.108.062331</pub-id>.<pub-id pub-id-type="pmid">18827180</pub-id></mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Hellinger</surname><given-names>R.</given-names></name>; <name><surname>Koehbach</surname><given-names>J.</given-names></name>; <name><surname>Fedchuk</surname><given-names>H.</given-names></name>; <name><surname>Sauer</surname><given-names>B.</given-names></name>; <name><surname>Huber</surname><given-names>R.</given-names></name>; <name><surname>Gruber</surname><given-names>C. W.</given-names></name>; <name><surname>Grundemann</surname><given-names>C.</given-names></name>
<article-title>Immunosuppressive activity of an
aqueous Viola tricolor herbal extract</article-title>. <source>J. Ethnopharmacol.</source>
<year>2014</year>, <volume>151</volume>, <fpage>299</fpage>&#x02013;<lpage>306</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2013.10.044</pub-id>.<pub-id pub-id-type="pmid">24216163</pub-id></mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Klovekorn</surname><given-names>W.</given-names></name>; <name><surname>Tepe</surname><given-names>A.</given-names></name>; <name><surname>Danesch</surname><given-names>U.</given-names></name>
<article-title>A randomized, double-blind, vehicle-controlled,
half-side comparison with a herbal ointment containing Mahonia aquifolium,
Viola tricolor and Centella asiatica for the treatment of mild-to-moderate
atopic dermatitis</article-title>. <source>Int. J. Clin. Pharmacol.
Ther.</source>
<year>2007</year>, <volume>45</volume>, <fpage>583</fpage>&#x02013;<lpage>91</lpage><pub-id pub-id-type="doi">10.5414/CPP45583</pub-id>.<pub-id pub-id-type="pmid">18077922</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Reuter</surname><given-names>J.</given-names></name>; <name><surname>Merfort</surname><given-names>I.</given-names></name>; <name><surname>Schempp</surname><given-names>C. M.</given-names></name>
<article-title>Botanicals in dermatology: an evidence-based
review</article-title>. <source>Am. J. Clin. Dermatol.</source>
<year>2010</year>, <volume>11</volume>, <fpage>247</fpage>&#x02013;<lpage>67</lpage><pub-id pub-id-type="doi">10.2165/11533220-000000000-00000</pub-id>.<pub-id pub-id-type="pmid">20509719</pub-id></mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Toiu</surname><given-names>A.</given-names></name>; <name><surname>Muntean</surname><given-names>E.</given-names></name>; <name><surname>Oniga</surname><given-names>I.</given-names></name>; <name><surname>Vostinaru</surname><given-names>O.</given-names></name>; <name><surname>Tamas</surname><given-names>M.</given-names></name>
<article-title>Pharmacognostic research on Viola tricolor L. (Violaceae)</article-title>. <source>Planta Med.</source>
<year>2009</year>, <volume>113</volume>, <fpage>264</fpage>&#x02013;<lpage>7</lpage><pub-id pub-id-type="doi">10.1055/s-0029-1234429</pub-id>.</mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Svangard</surname><given-names>E.</given-names></name>; <name><surname>Goransson</surname><given-names>U.</given-names></name>; <name><surname>Hocaoglu</surname><given-names>Z.</given-names></name>; <name><surname>Gullbo</surname><given-names>J.</given-names></name>; <name><surname>Larsson</surname><given-names>R.</given-names></name>; <name><surname>Claeson</surname><given-names>P.</given-names></name>; <name><surname>Bohlin</surname><given-names>L.</given-names></name>
<article-title>Cytotoxic cyclotides from Viola tricolor</article-title>. <source>J. Nat. Prod.</source>
<year>2004</year>, <volume>67</volume>, <fpage>144</fpage>&#x02013;<lpage>7</lpage><pub-id pub-id-type="doi">10.1021/np030101l</pub-id>.<pub-id pub-id-type="pmid">14987049</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Broussalis</surname><given-names>A. M.</given-names></name>; <name><surname>Goransson</surname><given-names>U.</given-names></name>; <name><surname>Coussio</surname><given-names>J. D.</given-names></name>; <name><surname>Ferraro</surname><given-names>G.</given-names></name>; <name><surname>Martino</surname><given-names>V.</given-names></name>; <name><surname>Claeson</surname><given-names>P.</given-names></name>
<article-title>First cyclotide from Hybanthus (Violaceae)</article-title>. <source>Phytochemistry</source>
<year>2001</year>, <volume>58</volume>, <fpage>47</fpage>&#x02013;<lpage>51</lpage><pub-id pub-id-type="doi">10.1016/S0031-9422(01)00173-X</pub-id>.<pub-id pub-id-type="pmid">11524112</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Burman</surname><given-names>R.</given-names></name>; <name><surname>Gruber</surname><given-names>C. W.</given-names></name>; <name><surname>Rizzardi</surname><given-names>K.</given-names></name>; <name><surname>Herrmann</surname><given-names>A.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>; <name><surname>Gupta</surname><given-names>M. P.</given-names></name>; <name><surname>Goransson</surname><given-names>U.</given-names></name>
<article-title>Cyclotide proteins and precursors
from the genus Gloeospermum: filling a blank spot in the cyclotide
map of Violaceae</article-title>. <source>Phytochemistry</source>
<year>2010</year>, <volume>71</volume>, <fpage>13</fpage>&#x02013;<lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2009.09.023</pub-id>.<pub-id pub-id-type="pmid">19879608</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Goransson</surname><given-names>U.</given-names></name>; <name><surname>Luijendijk</surname><given-names>T.</given-names></name>; <name><surname>Johansson</surname><given-names>S.</given-names></name>; <name><surname>Bohlin</surname><given-names>L.</given-names></name>; <name><surname>Claeson</surname><given-names>P.</given-names></name>
<article-title>Seven novel
macrocyclic polypeptides from Viola arvensis</article-title>. <source>J. Nat. Prod.</source>
<year>1999</year>, <volume>62</volume>, <fpage>283</fpage>&#x02013;<lpage>6</lpage><pub-id pub-id-type="doi">10.1021/np9803878</pub-id>.<pub-id pub-id-type="pmid">10075760</pub-id></mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Hashempour</surname><given-names>H.</given-names></name>; <name><surname>Koehbach</surname><given-names>J.</given-names></name>; <name><surname>Daly</surname><given-names>N. L.</given-names></name>; <name><surname>Ghassempour</surname><given-names>A.</given-names></name>; <name><surname>Gruber</surname><given-names>C. W.</given-names></name>
<article-title>Characterizing circular peptides in mixtures: sequence
fragment assembly of cyclotides from a violet plant by MALDI-TOF/TOF
mass spectrometry</article-title>. <source>Amino Acids</source>
<year>2013</year>, <volume>44</volume>, <fpage>581</fpage>&#x02013;<lpage>95</lpage><pub-id pub-id-type="doi">10.1007/s00726-012-1376-x</pub-id>.<pub-id pub-id-type="pmid">22890611</pub-id></mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Herrmann</surname><given-names>A.</given-names></name>; <name><surname>Burman</surname><given-names>R.</given-names></name>; <name><surname>Mylne</surname><given-names>J. S.</given-names></name>; <name><surname>Karlsson</surname><given-names>G.</given-names></name>; <name><surname>Gullbo</surname><given-names>J.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>; <name><surname>Clark</surname><given-names>R. J.</given-names></name>; <name><surname>Goransson</surname><given-names>U.</given-names></name>
<article-title>The alpine
violet, Viola biflora, is a rich source of cyclotides with potent
cytotoxicity</article-title>. <source>Phytochemistry</source>
<year>2008</year>, <volume>69</volume>, <fpage>939</fpage>&#x02013;<lpage>52</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2007.10.023</pub-id>.<pub-id pub-id-type="pmid">18191970</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Ireland</surname><given-names>D. C.</given-names></name>; <name><surname>Colgrave</surname><given-names>M. L.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>
<article-title>A novel suite of cyclotides from
Viola odorata: sequence variation and the implications for structure,
function and stability</article-title>. <source>Biochem. J.</source>
<year>2006</year>, <volume>400</volume>, <fpage>1</fpage>&#x02013;<lpage>12</lpage><pub-id pub-id-type="doi">10.1042/BJ20060627</pub-id>.<pub-id pub-id-type="pmid">16872274</pub-id></mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Simonsen</surname><given-names>S. M.</given-names></name>; <name><surname>Sando</surname><given-names>L.</given-names></name>; <name><surname>Ireland</surname><given-names>D. C.</given-names></name>; <name><surname>Colgrave</surname><given-names>M. L.</given-names></name>; <name><surname>Bharathi</surname><given-names>R.</given-names></name>; <name><surname>Goransson</surname><given-names>U.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>
<article-title>A continent of plant defense peptide
diversity: cyclotides in Australian Hybanthus (Violaceae)</article-title>. <source>Plant Cell</source>
<year>2005</year>, <volume>17</volume>, <fpage>3176</fpage>&#x02013;<lpage>3189</lpage><pub-id pub-id-type="doi">10.1105/tpc.105.034678</pub-id>.<pub-id pub-id-type="pmid">16199617</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Trabi</surname><given-names>M.</given-names></name>; <name><surname>Mylne</surname><given-names>J. S.</given-names></name>; <name><surname>Sando</surname><given-names>L.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>
<article-title>Circular proteins
from Melicytus (Violaceae) refine the conserved protein and gene architecture
of cyclotides</article-title>. <source>Org. Biomol. Chem.</source>
<year>2009</year>, <volume>7</volume>, <fpage>2378</fpage>&#x02013;<lpage>88</lpage><pub-id pub-id-type="doi">10.1039/b823020j</pub-id>.<pub-id pub-id-type="pmid">19462049</pub-id></mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Wang</surname><given-names>C. K.</given-names></name>; <name><surname>Colgrave</surname><given-names>M. L.</given-names></name>; <name><surname>Gustafson</surname><given-names>K. R.</given-names></name>; <name><surname>Ireland</surname><given-names>D. C.</given-names></name>; <name><surname>Goransson</surname><given-names>U.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>
<article-title>Anti-HIV cyclotides from the Chinese medicinal herb
Viola yedoensis</article-title>. <source>J. Nat. Prod.</source>
<year>2008</year>, <volume>71</volume>, <fpage>47</fpage>&#x02013;<lpage>52</lpage><pub-id pub-id-type="doi">10.1021/np070393g</pub-id>.<pub-id pub-id-type="pmid">18081258</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Yeshak</surname><given-names>M. Y.</given-names></name>; <name><surname>Burman</surname><given-names>R.</given-names></name>; <name><surname>Asres</surname><given-names>K.</given-names></name>; <name><surname>Goransson</surname><given-names>U.</given-names></name>
<article-title>Cyclotides
from an extreme habitat: characterization of cyclic peptides from
Viola abyssinica of the Ethiopian highlands</article-title>. <source>J. Nat. Prod.</source>
<year>2011</year>, <volume>74</volume>, <fpage>727</fpage>&#x02013;<lpage>31</lpage><pub-id pub-id-type="doi">10.1021/np100790f</pub-id>.<pub-id pub-id-type="pmid">21434649</pub-id></mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Chen</surname><given-names>B.</given-names></name>; <name><surname>Colgrave</surname><given-names>M. L.</given-names></name>; <name><surname>Wang</surname><given-names>C.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>
<article-title>Cycloviolacin H4,
a hydrophobic cyclotide from Viola hederaceae</article-title>. <source>J. Nat. Prod.</source>
<year>2006</year>, <volume>69</volume>, <fpage>23</fpage>&#x02013;<lpage>8</lpage><pub-id pub-id-type="doi">10.1021/np050317i</pub-id>.<pub-id pub-id-type="pmid">16441062</pub-id></mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>Gerlach</surname><given-names>S. L.</given-names></name>; <name><surname>Yeshak</surname><given-names>M.</given-names></name>; <name><surname>Goransson</surname><given-names>U.</given-names></name>; <name><surname>Roy</surname><given-names>U.</given-names></name>; <name><surname>Izadpanah</surname><given-names>R.</given-names></name>; <name><surname>Mondal</surname><given-names>D.</given-names></name>
<article-title>Cycloviolacin O2 (CyO2) suppresses productive infection
and augments the antiviral efficacy of nelfinavir in HIV-1 infected
monocytic cells</article-title>. <source>Biopolymers</source>
<year>2013</year>, <volume>100</volume>, <fpage>471</fpage>&#x02013;<lpage>9</lpage><pub-id pub-id-type="doi">10.1002/bip.22325</pub-id>.<pub-id pub-id-type="pmid">23897405</pub-id></mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>Goransson</surname><given-names>U.</given-names></name>; <name><surname>Herrmann</surname><given-names>A.</given-names></name>; <name><surname>Burman</surname><given-names>R.</given-names></name>; <name><surname>Haugaard-Jonsson</surname><given-names>L. M.</given-names></name>; <name><surname>Rosengren</surname><given-names>K. J.</given-names></name>
<article-title>The conserved glu in the cyclotide cycloviolacin O2
has a key structural role</article-title>. <source>ChemBioChem</source>
<year>2009</year>, <volume>10</volume>, <fpage>2354</fpage>&#x02013;<lpage>60</lpage><pub-id pub-id-type="doi">10.1002/cbic.200900342</pub-id>.<pub-id pub-id-type="pmid">19735083</pub-id></mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Goransson</surname><given-names>U.</given-names></name>; <name><surname>Svangard</surname><given-names>E.</given-names></name>; <name><surname>Claeson</surname><given-names>P.</given-names></name>; <name><surname>Bohlin</surname><given-names>L.</given-names></name>
<article-title>Novel strategies for
isolation and characterization of cyclotides: the discovery of bioactive
macrocyclic plant polypeptides in the Violaceae</article-title>. <source>Curr. Protein Pept. Sci.</source>
<year>2004</year>, <volume>5</volume>, <fpage>317</fpage>&#x02013;<lpage>29</lpage><pub-id pub-id-type="doi">10.2174/1389203043379495</pub-id>.<pub-id pub-id-type="pmid">15544528</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Herrmann</surname><given-names>A.</given-names></name>; <name><surname>Svangard</surname><given-names>E.</given-names></name>; <name><surname>Claeson</surname><given-names>P.</given-names></name>; <name><surname>Gullbo</surname><given-names>J.</given-names></name>; <name><surname>Bohlin</surname><given-names>L.</given-names></name>; <name><surname>Goransson</surname><given-names>U.</given-names></name>
<article-title>Key role of glutamic acid for the cytotoxic activity
of the cyclotide cycloviolacin O2</article-title>. <source>Cell. Mol.
Life Sci.</source>
<year>2006</year>, <volume>63</volume>, <fpage>235</fpage>&#x02013;<lpage>45</lpage><pub-id pub-id-type="doi">10.1007/s00018-005-5486-4</pub-id>.<pub-id pub-id-type="pmid">16389447</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Ireland</surname><given-names>D. C.</given-names></name>; <name><surname>Colgrave</surname><given-names>M. L.</given-names></name>; <name><surname>Nguyencong</surname><given-names>P.</given-names></name>; <name><surname>Daly</surname><given-names>N. L.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>
<article-title>Discovery
and characterization of a linear cyclotide from <italic>Viola odorata</italic>: Implications for the processing of circular proteins</article-title>. <source>J. Mol. Biol.</source>
<year>2006</year>, <volume>357</volume>, <fpage>1522</fpage>&#x02013;<lpage>1535</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2006.01.051</pub-id>.<pub-id pub-id-type="pmid">16488428</pub-id></mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Leta
Aboye</surname><given-names>T.</given-names></name>; <name><surname>Clark</surname><given-names>R. J.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>; <name><surname>Goransson</surname><given-names>U.</given-names></name>
<article-title>Ultra-stable
peptide scaffolds for protein engineering-synthesis and folding of
the circular cystine knotted cyclotide cycloviolacin O2</article-title>. <source>ChemBioChem</source>
<year>2008</year>, <volume>9</volume>, <fpage>103</fpage>&#x02013;<lpage>13</lpage><pub-id pub-id-type="doi">10.1002/cbic.200700357</pub-id>.<pub-id pub-id-type="pmid">18058973</pub-id></mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Svangard</surname><given-names>E.</given-names></name>; <name><surname>Burman</surname><given-names>R.</given-names></name>; <name><surname>Gunasekera</surname><given-names>S.</given-names></name>; <name><surname>Lovborg</surname><given-names>H.</given-names></name>; <name><surname>Gullbo</surname><given-names>J.</given-names></name>; <name><surname>Goransson</surname><given-names>U.</given-names></name>
<article-title>Mechanism of action of cytotoxic cyclotides: cycloviolacin
O2 disrupts lipid membranes</article-title>. <source>J. Nat. Prod.</source>
<year>2007</year>, <volume>70</volume>, <fpage>643</fpage>&#x02013;<lpage>7</lpage><pub-id pub-id-type="doi">10.1021/np070007v</pub-id>.<pub-id pub-id-type="pmid">17378610</pub-id></mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Koehbach</surname><given-names>J.</given-names></name>; <name><surname>Attah</surname><given-names>A. F.</given-names></name>; <name><surname>Berger</surname><given-names>A.</given-names></name>; <name><surname>Hellinger</surname><given-names>R.</given-names></name>; <name><surname>Kutchan</surname><given-names>T. M.</given-names></name>; <name><surname>Carpenter</surname><given-names>E. J.</given-names></name>; <name><surname>Rolf</surname><given-names>M.</given-names></name>; <name><surname>Sonibare</surname><given-names>M. A.</given-names></name>; <name><surname>Moody</surname><given-names>J. O.</given-names></name>; <name><surname>Wong</surname><given-names>G. K.</given-names></name>; <name><surname>Dessein</surname><given-names>S.</given-names></name>; <name><surname>Greger</surname><given-names>H.</given-names></name>; <name><surname>Gruber</surname><given-names>C. W.</given-names></name>
<article-title>Cyclotide discovery in Gentianales revisited-identification
and characterization of cyclic cystine-knot peptides and their phylogenetic
distribution in Rubiaceae plants</article-title>. <source>Biopolymers</source>
<year>2013</year>, <volume>100</volume>, <fpage>438</fpage>&#x02013;<lpage>52</lpage><pub-id pub-id-type="doi">10.1002/bip.22328</pub-id>.<pub-id pub-id-type="pmid">23897543</pub-id></mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Poth</surname><given-names>A. G.</given-names></name>; <name><surname>Colgrave</surname><given-names>M. L.</given-names></name>; <name><surname>Lyons</surname><given-names>R. E.</given-names></name>; <name><surname>Daly</surname><given-names>N. L.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>
<article-title>Discovery
of an unusual biosynthetic origin for circular proteins in legumes</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>2011</year>, <volume>108</volume>, <fpage>10127</fpage>&#x02013;<lpage>32</lpage><pub-id pub-id-type="doi">10.1073/pnas.1103660108</pub-id>.<pub-id pub-id-type="pmid">21593408</pub-id></mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name><surname>Zhang</surname><given-names>J.</given-names></name>; <name><surname>Li</surname><given-names>J.</given-names></name>; <name><surname>Huang</surname><given-names>Z.</given-names></name>; <name><surname>Yang</surname><given-names>B.</given-names></name>; <name><surname>Zhang</surname><given-names>X.</given-names></name>; <name><surname>Li</surname><given-names>D.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>; <name><surname>Baker</surname><given-names>A. J.</given-names></name>; <name><surname>Shu</surname><given-names>W.</given-names></name>; <name><surname>Liao</surname><given-names>B.</given-names></name>
<article-title>Transcriptomic
screening for cyclotides and other cysteine-rich proteins in the metallophyte
Viola baoshanensis</article-title>. <source>J. Plant Physiol.</source>
<year>2015</year>, <volume>178</volume>, <fpage>17</fpage>&#x02013;<lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.jplph.2015.01.017</pub-id>.<pub-id pub-id-type="pmid">25756919</pub-id></mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name><surname>Nguyen</surname><given-names>G. K.</given-names></name>; <name><surname>Lim</surname><given-names>W. H.</given-names></name>; <name><surname>Nguyen</surname><given-names>P. Q.</given-names></name>; <name><surname>Tam</surname><given-names>J. P.</given-names></name>
<article-title>Novel cyclotides
and uncyclotides with highly shortened precursors from Chassalia chartacea
and effects of methionine oxidation on bioactivities</article-title>. <source>J. Biol. Chem.</source>
<year>2012</year>, <volume>287</volume>, <fpage>17598</fpage>&#x02013;<lpage>607</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.338970</pub-id>.<pub-id pub-id-type="pmid">22467870</pub-id></mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>Jordon-Thaden</surname><given-names>I. E.</given-names></name>; <name><surname>Chanderbali</surname><given-names>A. S.</given-names></name>; <name><surname>Gitzendanner</surname><given-names>M. A.</given-names></name>; <name><surname>Soltis</surname><given-names>D. E.</given-names></name>
<article-title>Modified CTAB and
TRIzol protocols improve RNA extraction from chemically complex Embryophyta</article-title>. <source>Appl. Plant Sci.</source>
<year>2015</year>, <volume>3</volume>, <fpage>1400105</fpage><pub-id pub-id-type="doi">10.3732/apps.1400105</pub-id>.</mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name><surname>Xie</surname><given-names>Y.</given-names></name>; <name><surname>Wu</surname><given-names>G.</given-names></name>; <name><surname>Tang</surname><given-names>J.</given-names></name>; <name><surname>Luo</surname><given-names>R.</given-names></name>; <name><surname>Patterson</surname><given-names>J.</given-names></name>; <name><surname>Liu</surname><given-names>S.</given-names></name>; <name><surname>Huang</surname><given-names>W.</given-names></name>; <name><surname>He</surname><given-names>G.</given-names></name>; <name><surname>Gu</surname><given-names>S.</given-names></name>; <name><surname>Li</surname><given-names>S.</given-names></name>; <name><surname>Zhou</surname><given-names>X.</given-names></name>; <name><surname>Lam</surname><given-names>T. W.</given-names></name>; <name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Xu</surname><given-names>X.</given-names></name>; <name><surname>Wong</surname><given-names>G. K.</given-names></name>; <name><surname>Wang</surname><given-names>J.</given-names></name>
<article-title>SOAPdenovo-Trans: de novo transcriptome
assembly with short RNA-Seq reads</article-title>. <source>Bioinformatics</source>
<year>2014</year>, <volume>30</volume>, <fpage>1660</fpage>&#x02013;<lpage>6</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu077</pub-id>.<pub-id pub-id-type="pmid">24532719</pub-id></mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name><surname>Colgrave</surname><given-names>M. L.</given-names></name>; <name><surname>Poth</surname><given-names>A. G.</given-names></name>; <name><surname>Kaas</surname><given-names>Q.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>
<article-title>A new &#x02033;era&#x02033;
for cyclotide sequencing</article-title>. <source>Biopolymers</source>
<year>2010</year>, <volume>94</volume>, <fpage>592</fpage>&#x02013;<lpage>601</lpage><pub-id pub-id-type="doi">10.1002/bip.21400</pub-id>.<pub-id pub-id-type="pmid">20564007</pub-id></mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name><surname>Vizcaino</surname><given-names>J. A.</given-names></name>; <name><surname>Cote</surname><given-names>R. G.</given-names></name>; <name><surname>Csordas</surname><given-names>A.</given-names></name>; <name><surname>Dianes</surname><given-names>J. A.</given-names></name>; <name><surname>Fabregat</surname><given-names>A.</given-names></name>; <name><surname>Foster</surname><given-names>J. M.</given-names></name>; <name><surname>Griss</surname><given-names>J.</given-names></name>; <name><surname>Alpi</surname><given-names>E.</given-names></name>; <name><surname>Birim</surname><given-names>M.</given-names></name>; <name><surname>Contell</surname><given-names>J.</given-names></name>; <name><surname>O&#x02019;Kelly</surname><given-names>G.</given-names></name>; <name><surname>Schoenegger</surname><given-names>A.</given-names></name>; <name><surname>Ovelleiro</surname><given-names>D.</given-names></name>; <name><surname>Perez-Riverol</surname><given-names>Y.</given-names></name>; <name><surname>Reisinger</surname><given-names>F.</given-names></name>; <name><surname>Rios</surname><given-names>D.</given-names></name>; <name><surname>Wang</surname><given-names>R.</given-names></name>; <name><surname>Hermjakob</surname><given-names>H.</given-names></name>
<article-title>The PRoteomics
IDEntifications (PRIDE) database and associated tools: status in 2013</article-title>. <source>Nucleic Acids Res.</source>
<year>2013</year>, <volume>41</volume>, <fpage>D1063</fpage>&#x02013;<lpage>9</lpage><pub-id pub-id-type="doi">10.1093/nar/gks1262</pub-id>.<pub-id pub-id-type="pmid">23203882</pub-id></mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name><surname>Gran</surname><given-names>L.</given-names></name>
<article-title>Oxytocic principles
of Oldenlandia affinis</article-title>. <source>Lloydia</source>
<year>1973</year>, <volume>36</volume>, <fpage>174</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">4744554</pub-id></mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>Gran</surname><given-names>L.</given-names></name>
<article-title>On the effect
of a polypeptide isolated from &#x0201c;Kalata-Kalata&#x0201d; (Oldenlandia
affinis DC) on the oestrogen dominated uterus</article-title>. <source>Acta Pharmacol. Toxicol.</source>
<year>1973</year>, <volume>33</volume>, <fpage>400</fpage>&#x02013;<lpage>8</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0773.1973.tb01541.x</pub-id>.</mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name><surname>Wang</surname><given-names>C. K.</given-names></name>; <name><surname>Hu</surname><given-names>S. H.</given-names></name>; <name><surname>Martin</surname><given-names>J. L.</given-names></name>; <name><surname>Sjogren</surname><given-names>T.</given-names></name>; <name><surname>Hajdu</surname><given-names>J.</given-names></name>; <name><surname>Bohlin</surname><given-names>L.</given-names></name>; <name><surname>Claeson</surname><given-names>P.</given-names></name>; <name><surname>Goransson</surname><given-names>U.</given-names></name>; <name><surname>Rosengren</surname><given-names>K. J.</given-names></name>; <name><surname>Tang</surname><given-names>J.</given-names></name>; <name><surname>Tan</surname><given-names>N. H.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>
<article-title>Combined
X-ray and NMR analysis of the stability of the cyclotide cystine knot
fold that underpins its insecticidal activity and potential use as
a drug scaffold</article-title>. <source>J. Biol. Chem.</source>
<year>2009</year>, <volume>284</volume>, <fpage>10672</fpage>&#x02013;<lpage>83</lpage><pub-id pub-id-type="doi">10.1074/jbc.M900021200</pub-id>.<pub-id pub-id-type="pmid">19211551</pub-id></mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><name><surname>Gruber</surname><given-names>C. W.</given-names></name>
<article-title>Global
cyclotide adventure: a journey dedicated to the discovery of circular
peptides from flowering plants</article-title>. <source>Biopolymers</source>
<year>2010</year>, <volume>94</volume>, <fpage>565</fpage>&#x02013;<lpage>72</lpage><pub-id pub-id-type="doi">10.1002/bip.21414</pub-id>.<pub-id pub-id-type="pmid">20564015</pub-id></mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal" id="cit48"><name><surname>Gerlach</surname><given-names>S. L.</given-names></name>; <name><surname>Goransson</surname><given-names>U.</given-names></name>; <name><surname>Kaas</surname><given-names>Q.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>; <name><surname>Mondal</surname><given-names>D.</given-names></name>; <name><surname>Gruber</surname><given-names>C. W.</given-names></name>
<article-title>A systematic approach to document cyclotide distribution
in plant species from genomic, transcriptomic, and peptidomic analysis</article-title>. <source>Biopolymers</source>
<year>2013</year>, <volume>100</volume>, <fpage>433</fpage>&#x02013;<lpage>7</lpage><pub-id pub-id-type="doi">10.1002/bip.22258</pub-id>.<pub-id pub-id-type="pmid">23907794</pub-id></mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal" id="cit49"><name><surname>Mulvenna</surname><given-names>J. P.</given-names></name>; <name><surname>Sando</surname><given-names>L.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>
<article-title>Processing of a 22 kDa precursor
protein to produce the circular protein tricyclon A</article-title>. <source>Structure</source>
<year>2005</year>, <volume>13</volume>, <fpage>691</fpage>&#x02013;<lpage>701</lpage><pub-id pub-id-type="doi">10.1016/j.str.2005.02.013</pub-id>.<pub-id pub-id-type="pmid">15893660</pub-id></mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal" id="cit50"><name><surname>Tang</surname><given-names>J.</given-names></name>; <name><surname>Wang</surname><given-names>C. K.</given-names></name>; <name><surname>Pan</surname><given-names>X.</given-names></name>; <name><surname>Yan</surname><given-names>H.</given-names></name>; <name><surname>Zeng</surname><given-names>G.</given-names></name>; <name><surname>Xu</surname><given-names>W.</given-names></name>; <name><surname>He</surname><given-names>W.</given-names></name>; <name><surname>Daly</surname><given-names>N. L.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>; <name><surname>Tan</surname><given-names>N.</given-names></name>
<article-title>Isolation
and characterization of cytotoxic cyclotides from Viola tricolor</article-title>. <source>Peptides</source>
<year>2010</year>, <volume>31</volume>, <fpage>1434</fpage>&#x02013;<lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.peptides.2010.05.004</pub-id>.<pub-id pub-id-type="pmid">20580652</pub-id></mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal" id="cit51"><name><surname>Nguyen</surname><given-names>G. K.</given-names></name>; <name><surname>Lian</surname><given-names>Y.</given-names></name>; <name><surname>Pang</surname><given-names>E. W.</given-names></name>; <name><surname>Nguyen</surname><given-names>P. Q.</given-names></name>; <name><surname>Tran</surname><given-names>T. D.</given-names></name>; <name><surname>Tam</surname><given-names>J. P.</given-names></name>
<article-title>Discovery of linear cyclotides in monocot plant Panicum
laxum of Poaceae family provides new insights into evolution and distribution
of cyclotides in plants</article-title>. <source>J. Biol. Chem.</source>
<year>2013</year>, <volume>288</volume>, <fpage>3370</fpage>&#x02013;<lpage>80</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.415356</pub-id>.<pub-id pub-id-type="pmid">23195955</pub-id></mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal" id="cit52"><name><surname>Plan</surname><given-names>M. R.</given-names></name>; <name><surname>Goransson</surname><given-names>U.</given-names></name>; <name><surname>Clark</surname><given-names>R. J.</given-names></name>; <name><surname>Daly</surname><given-names>N. L.</given-names></name>; <name><surname>Colgrave</surname><given-names>M. L.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>
<article-title>The cyclotide fingerprint in oldenlandia affinis: elucidation
of chemically modified, linear and novel macrocyclic peptides</article-title>. <source>ChemBioChem</source>
<year>2007</year>, <volume>8</volume>, <fpage>1001</fpage>&#x02013;<lpage>11</lpage><pub-id pub-id-type="doi">10.1002/cbic.200700097</pub-id>.<pub-id pub-id-type="pmid">17534989</pub-id></mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name><surname>Barbeta</surname><given-names>B. L.</given-names></name>; <name><surname>Marshall</surname><given-names>A. T.</given-names></name>; <name><surname>Gillon</surname><given-names>A. D.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>; <name><surname>Anderson</surname><given-names>M. A.</given-names></name>
<article-title>Plant cyclotides
disrupt epithelial cells in the midgut of lepidopteran larvae</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>2008</year>, <volume>105</volume>, <fpage>1221</fpage>&#x02013;<lpage>5</lpage><pub-id pub-id-type="doi">10.1073/pnas.0710338104</pub-id>.<pub-id pub-id-type="pmid">18202177</pub-id></mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal" id="cit54"><name><surname>Craik</surname><given-names>D. J.</given-names></name>; <name><surname>Malik</surname><given-names>U.</given-names></name>
<article-title>Cyclotide biosynthesis</article-title>. <source>Curr. Opin. Chem. Biol.</source>
<year>2013</year>, <volume>17</volume>, <fpage>546</fpage>&#x02013;<lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.cbpa.2013.05.033</pub-id>.<pub-id pub-id-type="pmid">23809361</pub-id></mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="journal" id="cit55"><name><surname>Gillon</surname><given-names>A. D.</given-names></name>; <name><surname>Saska</surname><given-names>I.</given-names></name>; <name><surname>Jennings</surname><given-names>C. V.</given-names></name>; <name><surname>Guarino</surname><given-names>R. F.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>; <name><surname>Anderson</surname><given-names>M. A.</given-names></name>
<article-title>Biosynthesis of circular proteins in plants</article-title>. <source>Plant J.</source>
<year>2008</year>, <volume>53</volume>, <fpage>505</fpage>&#x02013;<lpage>15</lpage><pub-id pub-id-type="doi">10.1111/j.1365-313X.2007.03357.x</pub-id>.<pub-id pub-id-type="pmid">18086282</pub-id></mixed-citation></ref><ref id="ref56"><mixed-citation publication-type="journal" id="cit56"><name><surname>Gruber</surname><given-names>C. W.</given-names></name>; <name><surname>Cemazar</surname><given-names>M.</given-names></name>; <name><surname>Clark</surname><given-names>R. J.</given-names></name>; <name><surname>Horibe</surname><given-names>T.</given-names></name>; <name><surname>Renda</surname><given-names>R. F.</given-names></name>; <name><surname>Anderson</surname><given-names>M. A.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>
<article-title>A novel plant protein-disulfide isomerase
involved in the oxidative folding of cystine knot defense proteins</article-title>. <source>J. Biol. Chem.</source>
<year>2007</year>, <volume>282</volume>, <fpage>20435</fpage>&#x02013;<lpage>46</lpage><pub-id pub-id-type="doi">10.1074/jbc.M700018200</pub-id>.<pub-id pub-id-type="pmid">17522051</pub-id></mixed-citation></ref><ref id="ref57"><mixed-citation publication-type="journal" id="cit57"><name><surname>Saska</surname><given-names>I.</given-names></name>; <name><surname>Gillon</surname><given-names>A. D.</given-names></name>; <name><surname>Hatsugai</surname><given-names>N.</given-names></name>; <name><surname>Dietzgen</surname><given-names>R. G.</given-names></name>; <name><surname>Hara-Nishimura</surname><given-names>I.</given-names></name>; <name><surname>Anderson</surname><given-names>M. A.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>
<article-title>An asparaginyl endopeptidase mediates
in vivo protein backbone cyclization</article-title>. <source>J. Biol.
Chem.</source>
<year>2007</year>, <volume>282</volume>, <fpage>29721</fpage>&#x02013;<lpage>8</lpage><pub-id pub-id-type="doi">10.1074/jbc.M705185200</pub-id>.<pub-id pub-id-type="pmid">17698845</pub-id></mixed-citation></ref><ref id="ref58"><mixed-citation publication-type="journal" id="cit58"><name><surname>Trabi</surname><given-names>M.</given-names></name>; <name><surname>Svangard</surname><given-names>E.</given-names></name>; <name><surname>Herrmann</surname><given-names>A.</given-names></name>; <name><surname>Goransson</surname><given-names>U.</given-names></name>; <name><surname>Claeson</surname><given-names>P.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>; <name><surname>Bohlin</surname><given-names>L.</given-names></name>
<article-title>Variations in cyclotide
expression in viola species</article-title>. <source>J. Nat. Prod.</source>
<year>2004</year>, <volume>67</volume>, <fpage>806</fpage>&#x02013;<lpage>10</lpage><pub-id pub-id-type="doi">10.1021/np034068e</pub-id>.<pub-id pub-id-type="pmid">15165141</pub-id></mixed-citation></ref><ref id="ref59"><mixed-citation publication-type="journal" id="cit59"><name><surname>Trabi</surname><given-names>M.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>
<article-title>Tissue-specific expression of head-to-tail cyclized
miniproteins in Violaceae and structure determination of the root
cyclotide Viola hederacea root cyclotide1</article-title>. <source>Plant
Cell</source>
<year>2004</year>, <volume>16</volume>, <fpage>2204</fpage>&#x02013;<lpage>2216</lpage><pub-id pub-id-type="doi">10.1105/tpc.104.021790</pub-id>.<pub-id pub-id-type="pmid">15295104</pub-id></mixed-citation></ref><ref id="ref60"><mixed-citation publication-type="journal" id="cit60"><name><surname>Mylne</surname><given-names>J. S.</given-names></name>; <name><surname>Wang</surname><given-names>C. K.</given-names></name>; <name><surname>van der Weerden</surname><given-names>N. L.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>
<article-title>Cyclotides are a
component of the innate defense of Oldenlandia affinis</article-title>. <source>Biopolymers</source>
<year>2010</year>, <volume>94</volume>, <fpage>635</fpage>&#x02013;<lpage>46</lpage><pub-id pub-id-type="doi">10.1002/bip.21419</pub-id>.<pub-id pub-id-type="pmid">20564018</pub-id></mixed-citation></ref><ref id="ref61"><mixed-citation publication-type="journal" id="cit61"><name><surname>Seydel</surname><given-names>P.</given-names></name>; <name><surname>Gruber</surname><given-names>C. W.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>; <name><surname>Dornenburg</surname><given-names>H.</given-names></name>
<article-title>Formation
of cyclotides and variations in cyclotide expression in Oldenlandia
affinis suspension cultures</article-title>. <source>Appl. Microbiol.
Biotechnol.</source>
<year>2007</year>, <volume>77</volume>, <fpage>275</fpage>&#x02013;<lpage>84</lpage><pub-id pub-id-type="doi">10.1007/s00253-007-1159-6</pub-id>.<pub-id pub-id-type="pmid">17786427</pub-id></mixed-citation></ref><ref id="ref62"><mixed-citation publication-type="journal" id="cit62"><name><surname>Conlan</surname><given-names>B. F.</given-names></name>; <name><surname>Colgrave</surname><given-names>M. L.</given-names></name>; <name><surname>Gillon</surname><given-names>A. D.</given-names></name>; <name><surname>Guarino</surname><given-names>R.</given-names></name>; <name><surname>Craik</surname><given-names>D. J.</given-names></name>; <name><surname>Anderson</surname><given-names>M. A.</given-names></name>
<article-title>Insights into processing and cyclization events associated
with biosynthesis of the cyclic Peptide kalata B1</article-title>. <source>J. Biol. Chem.</source>
<year>2012</year>, <volume>287</volume>, <fpage>28037</fpage>&#x02013;<lpage>46</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.347823</pub-id>.<pub-id pub-id-type="pmid">22700963</pub-id></mixed-citation></ref><ref id="ref63"><mixed-citation publication-type="journal" id="cit63"><name><surname>Biass</surname><given-names>D.</given-names></name>; <name><surname>Violette</surname><given-names>A.</given-names></name>; <name><surname>Hulo</surname><given-names>N.</given-names></name>; <name><surname>Lisacek</surname><given-names>F.</given-names></name>; <name><surname>Favreau</surname><given-names>P.</given-names></name>; <name><surname>Stocklin</surname><given-names>R.</given-names></name>
<article-title>Uncovering intense protein diversification in a cone
snail venom gland using an integrative venomics approach</article-title>. <source>J. Proteome Res.</source>
<year>2015</year>, <volume>14</volume>, <fpage>628</fpage>&#x02013;<lpage>38</lpage><pub-id pub-id-type="doi">10.1021/pr500583u</pub-id>.<pub-id pub-id-type="pmid">25536169</pub-id></mixed-citation></ref><ref id="ref64"><mixed-citation publication-type="journal" id="cit64"><name><surname>Hekking</surname><given-names>W. H. A.</given-names></name>
<article-title>Studies
on Neotropical Violaceae. II. Arrangement of Leaves, Inflorescences
and Branchlets in Neotropical Rinorea</article-title>. <source>Flora</source>
<year>1988</year>, <volume>180</volume>, <fpage>345</fpage>&#x02013;<lpage>376</lpage>.</mixed-citation></ref></ref-list></back></article>